alprazolam and Anxiety Disorders
alprazolam has been researched along with Anxiety Disorders in 257 studies
Alprazolam: A triazolobenzodiazepine compound with antianxiety and sedative-hypnotic actions, that is efficacious in the treatment of PANIC DISORDERS, with or without AGORAPHOBIA, and in generalized ANXIETY DISORDERS. (From AMA Drug Evaluations Annual, 1994, p238)
alprazolam : A member of the class of triazolobenzodiazepines that is 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine carrying methyl, phenyl and chloro substituents at positions 1, 6 and 8 respectively. Alprazolam is only found in individuals that have taken this drug.
Anxiety Disorders: Persistent and disabling ANXIETY.
Research Excerpts
Excerpt | Relevance | Reference |
---|---|---|
"Results of this study indicate that panic disorder patients are more vulnerable to alprazolam withdrawal than patients with generalized anxiety disorder, and this may reflect a general diathesis of panic disorder patients to encounter more difficulty during drug withdrawal." | 9.07 | Alprazolam withdrawal in patients with panic disorder and generalized anxiety disorder: vulnerability and effect of carbamazepine. ( Colin, V; Klein, E; Lenox, RH; Stolk, J, 1994) |
"In a controlled trial of alprazolam and exposure in 154 patients with panic disorder with agoraphobia, relations between panic, anticipatory anxiety, and phobic avoidance were examined." | 9.07 | Relationship of panic, anticipatory anxiety, agoraphobia and global improvement in panic disorder with agoraphobia treated with alprazolam and exposure. ( Başoğlu, M; Kiliç, C; Kuch, K; Marks, IM; Noshirvani, H; O'Sullivan, G; Swinson, RP, 1994) |
"In a multicenter placebo-controlled study, the safety, side effects, and patient acceptance of alprazolam for the treatment of panic disorder and agoraphobia were examined." | 9.06 | Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety. ( Ballenger, JC; Burrows, GD; DuPont, RL; Noyes, R; Pecknold, JC; Rifkin, A; Rubin, RT; Swinson, RP, 1988) |
"A case is presented in which, by a double-blind, placebo-controlled trial, alprazolam was shown to produce reversible stuttering." | 9.05 | A case report of alprazolam-induced stuttering. ( Elliott, RL; Thomas, BJ, 1985) |
"The effect of genetic polymorphism of the CYP3A4 gene on the efficacy and safety profiles of alprazolam was demonstrated in a group of 105 patients with anxiety disorders comorbid with alcohol use disorder." | 7.96 | Effects of plasma concentration of micro-RNA Mir-27b and CYP3A4*22 on equilibrium concentration of alprazolam in patients with anxiety disorders comorbid with alcohol use disorder. ( Bryun, EA; Bure, IV; Golovinskii, PA; Grishina, EA; Koporov, SG; Pankratenko, EP; Petukhov, AE; Ryzhikova, KA; Skryabin, VY; Smirnov, VV; Sychev, DA; Zastrozhin, MS; Zastrozhina, AK, 2020) |
"Thirty-six patients with panic disorder (PD) and 35 patients with generalized anxiety disorder (GAD) participated in an open alprazolam treatment phase that preceded controlled withdrawal from alprazolam." | 7.69 | Clinical similarity and biological diversity in the response to alprazolam in patients with panic disorder and generalized anxiety disorder. ( Colin, V; Greenberg, A; Klein, E; Lenox, RH; Levy, N; Zilberman, I; Zinder, O, 1995) |
"A case is reported of delirium and seizures due to the abrupt withdrawal from the benzodiazepine alprazolam." | 7.67 | Delirium and seizures due to abrupt alprazolam withdrawal: case report. ( Levy, AB, 1984) |
"Seven patients with schizophrenia and panic attacks all showed marked improvement of positive and negative schizophrenic symptoms when alprazolam was openly added to antipsychotic medication." | 7.67 | Adjunctive alprazolam for schizophrenia with panic anxiety: clinical observation and pathogenetic implications. ( Kahn, JP; Klein, DF; Puertollano, MA; Schane, MD, 1988) |
"Seizures were observed following the withdrawal of alprazolam administered in therapeutic dose for 10 weeks." | 7.67 | Seizures following the withdrawal of alprazolam. ( Clancy, J; Coryell, WH; Crowe, RR; Gabel, J; Noyes, R; Perry, PJ; Yamada, T, 1986) |
"Clonazepam, a high-potency benzodiazepine marketed for the treatment of minor motor epilepsy, was used to treat 50 patients with panic disorder (N = 22) or agoraphobia with panic attacks (N = 28)." | 7.67 | Treatment of panic disorder and agoraphobia with clonazepam. ( Rosenbaum, JF; Spier, SA; Tesar, GE; Woods, SW, 1986) |
"Alprazolam therapy was effective and well tolerated at a mean daily dose of 5." | 6.67 | Maintenance drug treatment of panic disorder. I. Results of a prospective, placebo-controlled comparison of alprazolam and imipramine. ( Rickels, K; Schweizer, E; Weiss, S; Zavodnick, S, 1993) |
"Of 147 cancer patients who met entry levels of distress and completed the study, uncontrolled for site or disease stage, 70 were randomized to drug, 77 to relaxation." | 6.67 | A randomized clinical trial of alprazolam versus progressive muscle relaxation in cancer patients with anxiety and depressive symptoms. ( Berenson, S; Breitbart, W; Carpenter, PJ; Derogatis, L; Feldstein, M; Holland, JC; Morrow, GR; Schmale, A; Stefanek, M, 1991) |
"Data were drawn from 3 double-blind, randomized, placebo-controlled, published treatment trials: alprazolam for patients with premenstrual syndrome (PMS) and diazepam and lorazepam for patients with generalized anxiety disorder (GAD)." | 5.09 | Prior benzodiazepine exposure and benzodiazepine treatment outcome. ( Freeman, EW; Rickels, K, 2000) |
"Fifty-two subjects with panic disorder and generalized anxiety disorder were interviewed 12-18 months after they completed an acute treatment study (9-11 weeks) with alprazolam followed by blind and controlled drug discontinuation." | 5.08 | Subjective experience and attitudes towards participation in clinical trials among patients with anxiety disorders. ( Klein, E; Lenox, RH; Malel, D; Zilberman, I, 1997) |
"6%) of whom had a symptomatic generalized anxiety disorder, were entered into a randomized, double-blind, placebo-controlled, 8-week trial using alprazolam (up to 2 mg/day) as the active agent." | 5.08 | Effects of alprazolam on glucose regulation in diabetes. Results of double-blind, placebo-controlled trial. ( Carney, RM; Clouse, RE; Eisen, SA; Freedland, KE; Griffith, LS; Lustman, PJ; McGill, JB; Rubin, EH, 1995) |
"The reinforcing effects of alprazolam were investigated in 14 patients who had generalized anxiety or panic disorder, but were not current users/abusers of other psychoactive substances." | 5.08 | Alprazolam-reinforced medication use in outpatients with anxiety. ( Creson, DR; Meisch, RA; Roache, JD; Shah, NN; Stanley, MA, 1997) |
"In a controlled trial of alprazolam and exposure in 154 patients with panic disorder with agoraphobia, relations between panic, anticipatory anxiety, and phobic avoidance were examined." | 5.07 | Relationship of panic, anticipatory anxiety, agoraphobia and global improvement in panic disorder with agoraphobia treated with alprazolam and exposure. ( Başoğlu, M; Kiliç, C; Kuch, K; Marks, IM; Noshirvani, H; O'Sullivan, G; Swinson, RP, 1994) |
"Fifty-five young adult patients completed a study comparing alprazolam, propranolol, and placebo in the treatment of panic disorder and agoraphobia with panic attacks." | 5.07 | Alprazolam levels and response in panic disorder: preliminary results. ( Munjack, DJ; Palmer, R; Wincor, MZ, 1991) |
"Results of this study indicate that panic disorder patients are more vulnerable to alprazolam withdrawal than patients with generalized anxiety disorder, and this may reflect a general diathesis of panic disorder patients to encounter more difficulty during drug withdrawal." | 5.07 | Alprazolam withdrawal in patients with panic disorder and generalized anxiety disorder: vulnerability and effect of carbamazepine. ( Colin, V; Klein, E; Lenox, RH; Stolk, J, 1994) |
"In a double-blind, placebo-controlled study, the efficacy and safety of alprazolam was investigated in childhood and adolescent anxiety disorders." | 5.07 | Clinical, cognitive, and neurophysiological effects of alprazolam in children and adolescents with overanxious and avoidant disorders. ( Dubois, C; Ferguson, HB; Gauthier, B; Knott, V; Roberts, N; Simeon, JG; Wiggins, D, 1992) |
"The acute effects of diazepam on plasma GABA were determined in 18 patients with panic disorder, 13 patients with generalized anxiety disorder and 20 healthy controls." | 5.07 | Effect of acute and chronic benzodiazepines on plasma GABA in anxious patients and controls. ( Cowley, DS; Greenblatt, DJ; Hommer, D; Kramer, GL; Petty, F; Roy-Byrne, PP, 1992) |
"Under a double-blind procedure, 122 patients suffering from general anxiety disorders were randomly allocated to either alpidem (50 mg, three times a day) or alprazolam (0." | 5.07 | Comparison of the efficacy, safety and withdrawal of alpidem and alprazolam in anxious patients. ( Albizzati, MG; Bassi, S; Borghi, C; Frattola, L; Garreau, M; Morselli, PL; Piolti, R, 1994) |
"In a multicenter placebo-controlled study, the safety, side effects, and patient acceptance of alprazolam for the treatment of panic disorder and agoraphobia were examined." | 5.06 | Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety. ( Ballenger, JC; Burrows, GD; DuPont, RL; Noyes, R; Pecknold, JC; Rifkin, A; Rubin, RT; Swinson, RP, 1988) |
" A double blind study of alprazolam and placebo in 118 patients with agoraphobia and panic is presented." | 5.06 | Psychopharmacological treatment of panic disorder and related states: a placebo controlled study of alprazolam. ( Kuch, K; Pecknold, JC; Swinson, RP, 1987) |
" In this non-blind, eight-week trial of alprazolam in patients presenting with chest pain and found to have panic disorder, 15 of 20 met the single criterion for improvement: a 50 percent or greater reduction in panic frequency." | 5.06 | Pharmacotherapeutic treatment of panic disorder in patients presenting with chest pain. ( Anderson, S; Basha, IM; Beitman, BD; Flaker, G; Jayaratna, MA; Russell, B; Trombka, LH, 1989) |
"An open clinical trial of alprazolam therapy of patients with panic disorder or agoraphobia with panic attacks was undertaken to clarify certain issues not resolved by previous studies." | 5.06 | Alprazolam in the treatment of panic disorders. ( Campeas, R; Davies, SR; Fyer, AJ; Goetz, D; Gorman, JM; Klein, DF; Levin, A; Liebowitz, MR, 1986) |
"A double-blind study was carried out in 30 female patients with generalized anxiety disorders associated with depressive symptoms to compare the effectiveness and tolerability of etizolam and alprazolam." | 5.06 | Etizolam in the treatment of generalized anxiety disorder associated with depressive symptoms. ( Caddeo, S; Ecari, U; Pariante, F, 1989) |
"The antipanic efficacy of alprazolam and lorazepam was evaluated in 48 patients meeting DSM-III criteria for agoraphobia with panic attacks or panic disorder in a double-blind random assignment study." | 5.06 | Benzodiazepine treatment of panic disorder: a comparison of alprazolam and lorazepam. ( Charney, DS; Woods, SW, 1989) |
"A case is presented in which, by a double-blind, placebo-controlled trial, alprazolam was shown to produce reversible stuttering." | 5.05 | A case report of alprazolam-induced stuttering. ( Elliott, RL; Thomas, BJ, 1985) |
"Alprazolam is a benzodiazepine derivative that is currently used in the treatment of generalized anxiety, panic attacks with or without agoraphobia, and depression." | 4.82 | Clinical pharmacology, clinical efficacy, and behavioral toxicity of alprazolam: a review of the literature. ( Verster, JC; Volkerts, ER, 2004) |
"A review of the worldwide published literature was conducted to assess the efficacy and safety of alprazolam for the treatment of anxiety disorders, panic disorder, and depression in comparison with those of other active drugs (including other benzodiazepines and antidepressant medications)." | 4.78 | A comparison of the safety and efficacy of alprazolam versus other agents in the treatment of anxiety, panic, and depression: a review of the literature. ( Cohon, MS; Jonas, JM, 1993) |
" For panic disorder and agoraphobia with panic, the tricyclic antidepressants, the monoamine oxidase inhibitors, and the atypical benzodiazepine alprazolam have proved effective." | 4.77 | Pharmacotherapeutic considerations in anxiety disorders. ( Hollister, LE, 1986) |
"The effect of genetic polymorphism of the CYP3A4 gene on the efficacy and safety profiles of alprazolam was demonstrated in a group of 105 patients with anxiety disorders comorbid with alcohol use disorder." | 3.96 | Effects of plasma concentration of micro-RNA Mir-27b and CYP3A4*22 on equilibrium concentration of alprazolam in patients with anxiety disorders comorbid with alcohol use disorder. ( Bryun, EA; Bure, IV; Golovinskii, PA; Grishina, EA; Koporov, SG; Pankratenko, EP; Petukhov, AE; Ryzhikova, KA; Skryabin, VY; Smirnov, VV; Sychev, DA; Zastrozhin, MS; Zastrozhina, AK, 2020) |
"Doctors should closely monitor the severity of alprazolam dependence among long-term users, especially patients' levels of depression, beliefs in the necessity of alprazolam treatment, and their concerns over the adverse consequences of continued treatment with alprazolam." | 3.81 | Severity of alprazolam dependence and associated features among long-term alprazolam users from psychiatric outpatient clinics in Taiwan. ( Chen, ST; Chen, TT; Hwang, TJ; Ko, CH; Lin, JJ; Su, PW; Yen, CF; Yen, CN, 2015) |
" Clonazepam, with its relatively long half-life, permits less frequent dosing than possible with benzodiazepines with shorter half-lives and more continuous control of anxiety, although around 20% of patients experience unacceptable sedative effects or no reduction in anxiety." | 3.76 | High-potency benzodiazepines for short-term management of panic disorder: the U.S. experience. ( Tesar, GE, 1990) |
"Alprazolam is a triazolobenzodiazepine which is related to diazepam and other 1,4-benzodiazepines, and has a similar pharmacological profile." | 3.75 | Alprazolam: a review of its pharmacodynamic properties and efficacy in the treatment of anxiety and depression. ( Brogden, RN; Dawson, GW; Jue, SG, 1984) |
"Thirty-six patients with panic disorder (PD) and 35 patients with generalized anxiety disorder (GAD) participated in an open alprazolam treatment phase that preceded controlled withdrawal from alprazolam." | 3.69 | Clinical similarity and biological diversity in the response to alprazolam in patients with panic disorder and generalized anxiety disorder. ( Colin, V; Greenberg, A; Klein, E; Lenox, RH; Levy, N; Zilberman, I; Zinder, O, 1995) |
"Seven patients with schizophrenia and panic attacks all showed marked improvement of positive and negative schizophrenic symptoms when alprazolam was openly added to antipsychotic medication." | 3.67 | Adjunctive alprazolam for schizophrenia with panic anxiety: clinical observation and pathogenetic implications. ( Kahn, JP; Klein, DF; Puertollano, MA; Schane, MD, 1988) |
"Two patients treated with alprazolam for panic disorder and agoraphobia developed a manic episode." | 3.67 | Alprazolam-induced manic episode in two patients with panic disorder. ( Fleury, D; Pecknold, JC, 1986) |
"Sixty patients with agoraphobia with panic attacks or panic disorder who completed a 4-month combined drug and behavioral group treatment program and were discharged on a regimen of alprazolam were interviewed 1." | 3.67 | Clinical and medication outcome after short-term alprazolam and behavioral group treatment in panic disorder. 2.5 year naturalistic follow-up study. ( Charney, DS; Krystal, JH; Nagy, LM; Woods, SW, 1989) |
" To assess whether alprazolam alters noradrenergic function, the effects of alprazolam on baseline plasma free 3-methoxy-4-hydroxyphenylethyleneglycol (MHPG), and yohimbine-induced increases in plasma MHPG level, anxiety-nervousness, blood pressure, and somatic symptoms were studied in 14 patients with agoraphobia and panic disorder." | 3.67 | Noradrenergic function and the mechanism of action of antianxiety treatment. I. The effect of long-term alprazolam treatment. ( Charney, DS; Heninger, GR, 1985) |
"Seizures were observed following the withdrawal of alprazolam administered in therapeutic dose for 10 weeks." | 3.67 | Seizures following the withdrawal of alprazolam. ( Clancy, J; Coryell, WH; Crowe, RR; Gabel, J; Noyes, R; Perry, PJ; Yamada, T, 1986) |
"Clonazepam, a high-potency benzodiazepine marketed for the treatment of minor motor epilepsy, was used to treat 50 patients with panic disorder (N = 22) or agoraphobia with panic attacks (N = 28)." | 3.67 | Treatment of panic disorder and agoraphobia with clonazepam. ( Rosenbaum, JF; Spier, SA; Tesar, GE; Woods, SW, 1986) |
"A case is reported of delirium and seizures due to the abrupt withdrawal from the benzodiazepine alprazolam." | 3.67 | Delirium and seizures due to abrupt alprazolam withdrawal: case report. ( Levy, AB, 1984) |
"Ten cases are presented--two in detail--in which clonazepam was used successfully in patients with treatment-resistant panic disorder with or without agoraphobia." | 3.67 | Successful use of clonazepam in patients with treatment-resistant panic disorder. ( Rosenbaum, JF; Tesar, GE, 1986) |
" During the second 2 weeks, they all took the same dosage of the extended release formulation." | 2.69 | Medication side effects in anxious patients: negative placebo responses? ( Alexander, PE; Coleman, BS; Dempsey, GM; Jones, W; Swiontek, AM; Uhlenhuth, EH, 1998) |
" Grapefruit juice altered neither the plasma concentrations of alprazolam at any time points, any pharmacokinetic parameters, nor the majority of psychomotor function parameters in subjects." | 2.69 | Effects of repeated ingestion of grapefruit juice on the single and multiple oral-dose pharmacokinetics and pharmacodynamics of alprazolam. ( Furukori, H; Kaneko, S; Kondo, T; Ohkubo, T; Osanai, T; Otani, K; Sugawara, K; Uno, T; Yasui, N, 2000) |
"Alprazolam clearly was preferred over placebo; however, there were large between-subjects differences in the amount of medication used." | 2.69 | Predictors of individual differences in alprazolam self-medication. ( Oswald, LM; Rhoades, HM; Roache, JD, 1999) |
"Alprazolam therapy was effective and well tolerated at a mean daily dose of 5." | 2.67 | Maintenance drug treatment of panic disorder. I. Results of a prospective, placebo-controlled comparison of alprazolam and imipramine. ( Rickels, K; Schweizer, E; Weiss, S; Zavodnick, S, 1993) |
"Of 147 cancer patients who met entry levels of distress and completed the study, uncontrolled for site or disease stage, 70 were randomized to drug, 77 to relaxation." | 2.67 | A randomized clinical trial of alprazolam versus progressive muscle relaxation in cancer patients with anxiety and depressive symptoms. ( Berenson, S; Breitbart, W; Carpenter, PJ; Derogatis, L; Feldstein, M; Holland, JC; Morrow, GR; Schmale, A; Stefanek, M, 1991) |
"Sedation and ataxia were the most common side effects reported, but these effects were mild and transient and did not interfere with treatment outcome." | 2.67 | Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder. ( Cohen, LS; Herman, JB; Otto, MW; Pollack, MH; Rosenbaum, JF; Sachs, GS; Spier, SA; Tesar, GE, 1991) |
"Rebound anxiety and withdrawal symptoms were identified in a substantial minority of patients." | 2.67 | Controlled discontinuation of benzodiazepine treatment for patients with panic disorder. ( Cook, B; Garvey, MJ; Noyes, R; Suelzer, M, 1991) |
"Alprazolam-treated patients most frequently reported central nervous system-related side effects (drowsiness and sedation), while buspirone-treated patients most frequently reported gastrointestinal system-related side effects (appetite disturbances and abdominal complaints)." | 2.67 | Alprazolam versus buspirone in the treatment of outpatients with generalized anxiety disorder. ( Enkelmann, R, 1991) |
"Alprazolam was safe, effective, and well tolerated during the acute treatment of comorbid GAD and IBS; only a limited posttreatment rebound was observed." | 2.67 | An open label trial of alprazolam in comorbid irritable bowel syndrome and generalized anxiety disorder. ( Dunsmore, G; Luxenberg, M; Tollefson, GD; Tollefson, SL; Valentine, R, 1991) |
"The alprazolam effects were apparent by week 1; the imipramine effects by week 4." | 2.67 | Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder: results of a double-blind, placebo-controlled trial. ( Agras, WS; Clark, D; Ehlers, A; Hayward, C; King, R; Maddock, R; Margraf, J; Roth, WT; Taylor, CB, 1990) |
"Desipramine-treated subjects showed gradual improvement over the course of the study, and the improvement in week 1 was not so strongly predictive of overall improvement." | 2.67 | Antidepressant or antianxiety? A study of the efficacy of antidepressant medication. ( Edwards, J; Fawcett, J; Fogg, L; Kravitz, HM, 1990) |
" A 1 mg dosage increment produced, on the average, a corresponding 10 ng/ml increase in steady state level of the parent drug." | 2.67 | The relationship of alprazolam dose to steady-state plasma concentrations. ( Antal, EJ; Ciraulo, DA; Goldberg, DA; Greenblatt, DJ; Olson, DR; Phillips, JP; Rand, EH; Raskin, RB; Shader, RI; Smith, RB, 1990) |
"Alprazolam was more effective than imipramine and placebo on anticipatory anxiety and phobic symptoms." | 2.67 | Efficacy and safety of alprazolam, imipramine and placebo in treating panic disorder. A Scandinavian multicenter study. ( Andersch, S; Bech, P; Bruun-Hansen, J; Hanson, L; Kullingsjö, H; Lorentzen, K; Mellergård, M; Ottosson, JO; Rasmussen, S; Rosenberg, NK, 1991) |
"Buspirone was compared to alprazolam and lorazepam in the treatment of generalized anxiety disorder in a 4-week, double-blind study of 60 patients." | 2.66 | Low-sedation potential of buspirone compared with alprazolam and lorazepam in the treatment of anxious patients: a double-blind study. ( Cohn, JB; Wilcox, CS, 1986) |
" In a 6-week, double-blind, parallel-design study with flexible dosage scheduling, the authors compared the effects of alprazolam with those of imipramine in 60 patients who had generalized anxiety disorder." | 2.66 | Differential effects of alprazolam and imipramine in generalized anxiety disorder: somatic versus psychic symptoms. ( Hoehn-Saric, R; McLeod, DR; Zimmerli, WD, 1988) |
"Alprazolam treatment in eight patients markedly attenuated anxiety increases during rebreathing." | 2.66 | Carbon dioxide sensitivity in panic anxiety. Ventilatory and anxiogenic response to carbon dioxide in healthy subjects and patients with panic anxiety before and after alprazolam treatment. ( Charney, DS; Goodman, WK; Heninger, GR; Loke, J; Redmond, DE; Woods, SW, 1986) |
"Alprazolam was found to be effective and well tolerated." | 2.66 | Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment. ( Ballenger, JC; Burrows, GD; DuPont, RL; Lesser, IM; Noyes, R; Pecknold, JC; Rifkin, A; Swinson, RP, 1988) |
"Alprazolam was effective in reducing panic and depressive symptomatology in both depressed and nondepressed subjects with panic disorder." | 2.66 | Secondary depression in panic disorder and agoraphobia. I. Frequency, severity, and response to treatment. ( Burrows, GD; DuPont, RL; Lesser, IM; Lydiard, RB; Noyes, R; Pecknold, JC; Rifkin, A; Rubin, RT; Swinson, RP, 1988) |
"No serious or life-threatening withdrawal symptoms were reported, but distinct, transient, mild to moderate withdrawal syndrome occurred in 35% of the alprazolam-treated group and in none of the placebo-treated group." | 2.66 | Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. III. Discontinuation effects. ( Kuch, K; Lewis, CP; Pecknold, JC; Swinson, RP, 1988) |
"Alprazolam was as effective as diazepam in the relief of anxiety as measured by the Hamilton Anxiety Rating Scale, Physician's Global Impressions, Patient's Global Impressions, Hopkins Symptom Checklist and Target Symptoms Record." | 2.65 | Double-blind comparison of alprazolam and diazepam for subchronic withdrawal from alcohol. ( Kolin, IS; Linet, OI, 1981) |
"Alprazolam was more effective than placebo as measured by the Hamilton Anxiety Rating Scale, the Self-Rating Symptom Scale, Target Symptoms, Physician's Global Impressions, and Patient's Global Impressions." | 2.65 | Alprazolam in clinically anxious patients with depressed mood. ( Aden, GC, 1983) |
"Alprazolam was more effective than placebo on all five measures of efficacy and, on several parameters, more effective than diazepam as well." | 2.65 | Anxiolytic efficacy of alprazolam compared to diazepam and placebo. ( Maletzky, BM, 1980) |
" Patients were allocated at random to receive alprazolam, in a dosage of 0." | 2.65 | Alprazolam in the treatment of neurotic anxiety. ( Kerry, RJ; McDermott, CM, 1983) |
"Both alprazolam and diazepam were superior to placebo for the treatment of the clinical anxiety syndrome throughout a four-week double-blind multiclinic trial in 976 outpatients." | 2.65 | Multicenter double-blind efficacy and safety study comparing alprazolam, diazepam and placebo in clinically anxious patients. ( Cohn, JB, 1981) |
" While their association with sexual dysfunction may be intolerable for some adults, these drugs may be more appropriate than the benzodiazepines because their chronic use does not lead to dependence." | 2.41 | Pharmacotherapy of generalized anxiety disorder. ( Rickels, K; Rynn, M, 2002) |
" Eighty-two percent (39) of the patients rated clonazepam as being "better" than alprazolam due to decreased dosing frequency and lack of interdose anxiety." | 2.37 | Rebound anxiety in panic disorder patients treated with shorter-acting benzodiazepines. ( Brotman, AW; Herman, JB; Rosenbaum, JF, 1987) |
" A dose-response effect was evident for PGB that reached a plateau at a dose of 300 mg/d." | 1.36 | Comparative efficacy of pregabalin and benzodiazepines in treating the psychic and somatic symptoms of generalized anxiety disorder. ( Feltner, DE; Herman, B; Lydiard, RB; Rickels, K, 2010) |
"Psychiatrists treated major depressive disorder in advanced cancer patients on the basis of the algorithm." | 1.35 | Clinical experience of the use of a pharmacological treatment algorithm for major depressive disorder in patients with advanced cancer. ( Akechi, T; Akizuki, N; Ito, T; Nakano, T; Okamura, M; Shimizu, K; Uchitomi, Y, 2008) |
" Olanzapine (orally disintegrating tablets) in combination with alprazolam was used successfully to relieve this terminally ill patient's anxiety and tension improving his relationship with his physicians and his daily life." | 1.34 | Sublingual use of olanzapine in combination with alprazolam to treat agitation in a terminally ill patient receiving parenteral nutrition. ( Douzenis, A; Economopoulos, T; Lykouras, L; Michopoulos, I; Soldatos, CR, 2007) |
"In our case of a patient with recurrent major depressive disorder, subthreshold anxiety disorder and addiction to alprazolam, topiramate appears to be efficient and safe in alprazolam withdrawal." | 1.33 | Topiramate use in alprazolam addiction. ( Christodoulou, C; Douzenis, A; Lykouras, L; Michopoulos, I, 2006) |
"In 2 patients Graves' disease occurred in the setting of previously established euthyroid panic disorder." | 1.29 | Graves'disease after the onset of panic disorder. ( Kubo, C; Matsubayashi, S; Matsumoto, Y; Morita, T; Mukuta, T; Tamagawa, K; Tamaí, H, 1996) |
" Treatment failures most often result from an inadequate medication trial (ie, trial too brief or dosage inadequate); with adequate treatment most patients with panic disorder can be helped." | 1.28 | Panic disorder: diagnosis and treatment. ( O'Boyle, M, 1989) |
"All had withdrawal symptoms, six demonstrated tolerance, and at least four had substantial social or occupational impairment secondary to drug use." | 1.27 | Alprazolam dependence in seven patients. ( Juergens, SM; Morse, RM, 1988) |
"Alprazolam treatment is effective for panic disorder, but its major disadvantages include possible dependence and withdrawal symptoms upon discontinuation." | 1.27 | Preliminary evidence for the utility of carbamazepine in alprazolam withdrawal. ( Klein, E; Post, RM; Uhde, TW, 1986) |
"Alprazolam treatment led to a complete remission of panic attacks in 85% of the patients; panics ceased within an average of 6 days, at a mean dose of 2." | 1.27 | Alprazolam treatment for panic disorders. ( Alexander, DD; Alexander, PE, 1986) |
" Subsequent administration of an equivalent dosage of lorazepam did not induce manic symptoms." | 1.27 | A case of alprazolam, but not lorazepam, inducing manic symptoms. ( Charney, DS; Goodman, WK, 1987) |
"Alprazolam treatment was tapered in 17 panic patients at a rate of 10% of the starting dose every 3 days." | 1.27 | Discontinuation of alprazolam treatment in panic patients. ( Campeas, R; Davies, SO; Fyer, AJ; Goetz, D; Gorman, JM; Klein, DF; Levin, A; Liebowitz, MR, 1987) |
"Alprazolam is a triazolobenzodiazepine, a derivative of the benzodiazepines." | 1.26 | Alprazolam (Xanax, the Upjohn Company). ( Evans, RL, 1981) |
Research
Studies (257)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 120 (46.69) | 18.7374 |
1990's | 95 (36.96) | 18.2507 |
2000's | 26 (10.12) | 29.6817 |
2010's | 14 (5.45) | 24.3611 |
2020's | 2 (0.78) | 2.80 |
Authors
Authors | Studies |
---|---|
Zastrozhin, MS | 1 |
Skryabin, VY | 1 |
Smirnov, VV | 1 |
Petukhov, AE | 1 |
Pankratenko, EP | 1 |
Zastrozhina, AK | 1 |
Grishina, EA | 1 |
Ryzhikova, KA | 1 |
Bure, IV | 1 |
Golovinskii, PA | 1 |
Koporov, SG | 1 |
Bryun, EA | 1 |
Sychev, DA | 1 |
Hassan Basri, M | 1 |
Khoo, CS | 1 |
Che Hamzah, J | 1 |
Romero-Cerecero, O | 1 |
Islas-Garduño, AL | 1 |
Zamilpa, A | 1 |
Herrera-Arellano, A | 1 |
Jiménez-Ferrer, E | 1 |
Tortoriello, J | 1 |
Hlal, H | 1 |
Barrimi, M | 1 |
Kettani, N | 1 |
Rammouz, I | 1 |
Aalouane, R | 1 |
Poma, SZ | 1 |
Merlo-Pich, E | 1 |
Bettica, P | 1 |
Bani, M | 1 |
Fina, P | 1 |
Ziviani, L | 1 |
Milleri, S | 1 |
Chen, TT | 1 |
Ko, CH | 1 |
Chen, ST | 1 |
Yen, CN | 1 |
Su, PW | 1 |
Hwang, TJ | 1 |
Lin, JJ | 1 |
Yen, CF | 1 |
Siracusa, C | 1 |
Stepita, ME | 1 |
Türkoğlu, S | 1 |
Soria, CA | 1 |
Remedi, C | 1 |
Núñez, DA | 1 |
D'Alessio, L | 1 |
Roldán, EJ | 1 |
Brown, GG | 1 |
Ostrowitzki, S | 1 |
Stein, MB | 1 |
von Kienlin, M | 1 |
Liu, TT | 1 |
Simmons, A | 1 |
Wierenga, C | 1 |
Stein, OY | 1 |
Bruns, A | 1 |
Bischoff-Grethe, A | 1 |
Paulus, M | 1 |
Bailey, JE | 1 |
Papadopoulos, A | 1 |
Seddon, K | 1 |
Nutt, DJ | 1 |
Feltner, D | 1 |
Hill, C | 1 |
Lenderking, W | 1 |
Williams, V | 1 |
Morlock, R | 1 |
Lydiard, RB | 9 |
Rickels, K | 8 |
Herman, B | 1 |
Feltner, DE | 2 |
Zoberi, K | 1 |
Pollard, CA | 1 |
García-Gutiérrez, MS | 1 |
Manzanares, J | 1 |
Petrić, D | 1 |
Peitl, MV | 1 |
Peitl, V | 1 |
Hadley, SJ | 1 |
Mandel, FS | 1 |
Schweizer, E | 2 |
Stahl, SM | 1 |
Jaiswal, AK | 1 |
Rynn, M | 1 |
Möller, HJ | 2 |
Klein, E | 5 |
Boerner, RJ | 1 |
Verster, JC | 1 |
Volkerts, ER | 1 |
Ibadullaev, ZP | 1 |
Pollack, MH | 6 |
Zimbroff, DL | 1 |
Bielski, RJ | 1 |
Tobias, K | 1 |
Brock, JD | 1 |
Zornberg, GL | 1 |
Pande, AC | 1 |
Michopoulos, I | 2 |
Douzenis, A | 2 |
Christodoulou, C | 1 |
Lykouras, L | 2 |
Lee, SH | 1 |
Ahn, SC | 1 |
Lee, YJ | 1 |
Choi, TK | 1 |
Yook, KH | 1 |
Suh, SY | 1 |
Okamura, M | 1 |
Akizuki, N | 1 |
Nakano, T | 1 |
Shimizu, K | 1 |
Ito, T | 1 |
Akechi, T | 1 |
Uchitomi, Y | 1 |
Economopoulos, T | 1 |
Soldatos, CR | 1 |
Biermann, T | 1 |
Bleich, S | 1 |
Kornhuber, J | 1 |
Hillemacher, T | 1 |
Leonard, SK | 1 |
Dwyer, JM | 1 |
Sukoff Rizzo, SJ | 1 |
Platt, B | 1 |
Logue, SF | 1 |
Neal, SJ | 1 |
Malberg, JE | 1 |
Beyer, CE | 1 |
Schechter, LE | 1 |
Rosenzweig-Lipson, S | 1 |
Ring, RH | 1 |
Barthelmé, B | 1 |
Poirot, Y | 1 |
Maletzky, BM | 1 |
Evans, RL | 1 |
Cohn, JB | 2 |
Crook, T | 1 |
González, ER | 1 |
Csanalosi, I | 1 |
Greisman, P | 1 |
Cohen, D | 1 |
Werblowsky, J | 1 |
Ross, HA | 1 |
Harris, H | 1 |
Aden, GC | 1 |
Ruiz, AT | 1 |
Pies, R | 1 |
Claycomb, JB | 1 |
Draper, RJ | 1 |
Daly, I | 1 |
Levy, AB | 2 |
Chouinard, G | 1 |
Labonte, A | 1 |
Fontaine, R | 1 |
Annable, L | 1 |
Dawson, GW | 1 |
Jue, SG | 1 |
Brogden, RN | 1 |
Kerry, RJ | 1 |
McDermott, CM | 1 |
Tesar, GE | 6 |
Jenike, MA | 1 |
Rosenbaum, JF | 10 |
Woods, SW | 7 |
Groves, JE | 1 |
Klerman, GL | 6 |
Shehi, M | 1 |
Patterson, WM | 1 |
Elie, R | 1 |
Lamontagne, Y | 1 |
Talmud, J | 1 |
Straughan, JL | 1 |
Robins, AH | 1 |
Davis, J | 1 |
Bidder, TG | 1 |
Ballenger, JC | 9 |
Silberman, EK | 1 |
Sullivan, JL | 1 |
Sheehan, DV | 7 |
Van Winter, JT | 1 |
Stickler, GB | 1 |
Klein, DF | 6 |
Molnar, B | 1 |
Friedman, MJ | 1 |
Stolk, JM | 1 |
Harris, PQ | 1 |
Cooper, TB | 1 |
Kolin, IS | 1 |
Linet, OI | 1 |
Lustman, PJ | 1 |
Griffith, LS | 1 |
Clouse, RE | 1 |
Freedland, KE | 1 |
Eisen, SA | 1 |
Rubin, EH | 1 |
Carney, RM | 1 |
McGill, JB | 1 |
Romach, M | 1 |
Busto, U | 1 |
Somer, G | 1 |
Kaplan, HL | 1 |
Sellers, E | 1 |
Frattola, L | 1 |
Garreau, M | 1 |
Piolti, R | 1 |
Bassi, S | 1 |
Albizzati, MG | 1 |
Borghi, C | 1 |
Morselli, PL | 1 |
Steinberg, JR | 1 |
Başoğlu, M | 2 |
Marks, IM | 3 |
Kiliç, C | 1 |
Swinson, RP | 7 |
Noshirvani, H | 1 |
Kuch, K | 3 |
O'Sullivan, G | 1 |
Jonas, JM | 2 |
Piper, A | 1 |
Colin, V | 2 |
Stolk, J | 1 |
Lenox, RH | 3 |
Sussman, N | 1 |
Owens, MJ | 1 |
Vargas, MA | 1 |
Nemeroff, CB | 1 |
Olanoff, LS | 1 |
Greenblatt, DJ | 4 |
von Moltke, LL | 1 |
Harmatz, JS | 1 |
Ciraulo, DA | 2 |
Shader, RI | 2 |
Cohon, MS | 1 |
Barbee, JG | 1 |
Weiss, S | 1 |
Zavodnick, S | 1 |
Fava, GA | 1 |
Zinder, O | 1 |
Zilberman, I | 2 |
Levy, N | 1 |
Greenberg, A | 1 |
Reddy, J | 1 |
Khanna, S | 1 |
Anand, U | 1 |
Banerjee, A | 1 |
Matsubayashi, S | 1 |
Tamaí, H | 1 |
Matsumoto, Y | 1 |
Tamagawa, K | 1 |
Mukuta, T | 1 |
Morita, T | 1 |
Kubo, C | 1 |
Raj, AB | 1 |
Harnett-Sheehan, K | 1 |
Dorotheo, J | 1 |
Sheehan, MF | 1 |
Trehan, R | 1 |
Knapp, E | 1 |
Swiontek, A | 1 |
Coleman, B | 1 |
Roache, JD | 2 |
Stanley, MA | 1 |
Creson, DR | 1 |
Shah, NN | 1 |
Meisch, RA | 1 |
Freeman, S | 1 |
Haida, M | 1 |
Itoh, K | 1 |
Malel, D | 1 |
Uhlenhuth, EH | 1 |
Alexander, PE | 2 |
Dempsey, GM | 1 |
Jones, W | 1 |
Coleman, BS | 1 |
Swiontek, AM | 1 |
Covelli, V | 1 |
Maffione, AB | 1 |
Nacci, C | 1 |
Tatò, E | 1 |
Jirillo, E | 1 |
Matthews, J | 1 |
Scott, EL | 1 |
Gelpin, E | 1 |
Bonne, O | 1 |
Peri, T | 1 |
Brandes, D | 1 |
Shalev, AY | 1 |
Yamada, S | 2 |
Yajima, J | 2 |
Harano, M | 1 |
Miki, K | 1 |
Nakamura, J | 1 |
Tsuda, A | 2 |
Shoji, H | 1 |
Maeda, H | 2 |
Tanaka, M | 2 |
Yamauchi, K | 1 |
Oswald, LM | 1 |
Rhoades, HM | 1 |
Freeman, EW | 1 |
Yasui, N | 1 |
Kondo, T | 1 |
Furukori, H | 1 |
Kaneko, S | 1 |
Ohkubo, T | 1 |
Uno, T | 1 |
Osanai, T | 1 |
Sugawara, K | 1 |
Otani, K | 1 |
Volz, HP | 1 |
Reimann, IW | 1 |
Stoll, KD | 1 |
Frémont, P | 1 |
Bentué-Ferrer, D | 1 |
Reymann, JM | 1 |
Tribut, O | 1 |
Allain, H | 1 |
Vasar, E | 1 |
Bourin, M | 1 |
Lapierre, YD | 1 |
Lauerma, H | 1 |
Sandyk, R | 1 |
Dann, LC | 1 |
Sengün, S | 1 |
McCann, UD | 1 |
Ricaurte, GA | 1 |
Roy-Byrne, PP | 2 |
Cowley, DS | 3 |
Hommer, D | 1 |
Kramer, GL | 1 |
Petty, F | 1 |
Simeon, JG | 2 |
Ferguson, HB | 2 |
Knott, V | 1 |
Roberts, N | 1 |
Gauthier, B | 1 |
Dubois, C | 1 |
Wiggins, D | 1 |
García-Campayo, JJ | 1 |
Febrel Bordeje, M | 1 |
Campos Ródenas, R | 1 |
García Mur, MC | 1 |
Glod, CA | 1 |
Tollefson, GD | 2 |
Luxenberg, M | 1 |
Valentine, R | 1 |
Dunsmore, G | 1 |
Tollefson, SL | 1 |
Enkelmann, R | 1 |
Buller, R | 4 |
Maier, W | 5 |
Goldenberg, IM | 1 |
Lavori, PW | 1 |
Benkert, O | 2 |
Rosenberg, R | 7 |
Argyle, N | 2 |
Roth, M | 1 |
Brandon, S | 1 |
Andersch, S | 1 |
Rosenberg, NK | 4 |
Kullingsjö, H | 1 |
Ottosson, JO | 6 |
Bech, P | 7 |
Bruun-Hansen, J | 2 |
Hanson, L | 1 |
Lorentzen, K | 2 |
Mellergård, M | 7 |
Rasmussen, S | 1 |
Beck, P | 1 |
Rimón, R | 2 |
Kultalahti, ER | 1 |
Kalli, A | 1 |
Koskinen, T | 1 |
Lepola, U | 2 |
Naarala, M | 1 |
Tick, E | 1 |
Dager, SR | 3 |
Avery, DH | 3 |
Dunner, DL | 4 |
Clark, DB | 2 |
Taylor, CB | 3 |
Roth, WT | 3 |
Hayward, C | 2 |
Ehlers, A | 3 |
Margraf, J | 3 |
Agras, WS | 3 |
Burrows, GD | 8 |
Norman, TR | 4 |
Judd, FK | 4 |
Marriott, PF | 2 |
Otto, MW | 2 |
Sachs, GS | 3 |
Herman, JB | 4 |
Cohen, LS | 2 |
Spier, SA | 2 |
Sheikh, J | 1 |
Deltito, JA | 1 |
Noyes, R | 11 |
Garvey, MJ | 1 |
Cook, B | 3 |
Suelzer, M | 1 |
Holland, JC | 1 |
Morrow, GR | 1 |
Schmale, A | 1 |
Derogatis, L | 1 |
Stefanek, M | 1 |
Berenson, S | 1 |
Carpenter, PJ | 1 |
Breitbart, W | 1 |
Feldstein, M | 1 |
Edwards, JG | 1 |
Inman, WH | 1 |
Pearce, GL | 1 |
Rawson, NS | 1 |
Wincor, MZ | 1 |
Munjack, DJ | 2 |
Palmer, R | 1 |
Cox, BJ | 1 |
Endler, NS | 1 |
Melvin, JA | 1 |
Crowe, CM | 1 |
Laraia, MT | 4 |
Fossey, MD | 1 |
Zealberg, JJ | 1 |
Christie, S | 1 |
Bystritsky, A | 1 |
Pasnau, RO | 1 |
Mattick, RP | 1 |
Andrews, G | 1 |
Hadzi-Pavlovic, D | 1 |
Christensen, H | 1 |
Albus, M | 3 |
Nutzinger, D | 1 |
Shera, D | 2 |
King, R | 1 |
Maddock, R | 1 |
Clark, D | 1 |
Kravitz, HM | 1 |
Fogg, L | 1 |
Fawcett, J | 1 |
Edwards, J | 1 |
Udelman, HD | 1 |
Udelman, DL | 1 |
Bernstein, GA | 1 |
Garfinkel, BD | 1 |
Borchardt, CM | 1 |
Nightingale, SL | 1 |
O'Neil, C | 1 |
Asher, R | 1 |
Meltzer-Brody, S | 1 |
Davidson, JR | 1 |
McLeod, DR | 4 |
Hoehn-Saric, R | 4 |
Zimmerli, WD | 3 |
De Souza, EB | 1 |
Oliver, LK | 1 |
Khan, A | 1 |
Cowley, D | 1 |
Elder, J | 1 |
Roy-Byrne, P | 1 |
Lecrubier, Y | 1 |
Hippius, H | 1 |
Garvey, M | 2 |
Summers, R | 1 |
McIntyre, IM | 1 |
Armstrong, SM | 1 |
Klosko, JS | 1 |
Barlow, DH | 1 |
Tassinari, R | 1 |
Cerny, JA | 1 |
Jeffries, JJ | 1 |
Risse, SC | 1 |
Whitters, A | 1 |
Burke, J | 1 |
Chen, S | 1 |
Scurfield, RM | 1 |
Raskind, MA | 1 |
Sholomskas, AJ | 1 |
Antal, EJ | 1 |
Smith, RB | 1 |
Olson, DR | 1 |
Goldberg, DA | 1 |
Rand, EH | 1 |
Raskin, RB | 1 |
Phillips, JP | 1 |
Jolkkonen, J | 1 |
Riekkinen, P | 1 |
Tollefson, G | 1 |
Fishbain, DA | 1 |
Sunderland, G | 1 |
Friedman, S | 1 |
Rosenblum, LA | 1 |
Beitman, BD | 1 |
Basha, IM | 1 |
Trombka, LH | 1 |
Jayaratna, MA | 1 |
Russell, B | 1 |
Flaker, G | 1 |
Anderson, S | 1 |
De Albuquerque, A | 1 |
Cottraux, J | 1 |
Gentil, V | 1 |
Greist, J | 1 |
Hand, I | 1 |
Liberman, RL | 1 |
Relvas, JS | 1 |
Tobeña, A | 1 |
Tyrer, P | 1 |
Pariante, F | 1 |
Caddeo, S | 1 |
Ecari, U | 1 |
O'Boyle, M | 1 |
Hollander, E | 1 |
Fairbanks, J | 1 |
Decaria, C | 1 |
Liebowitz, MR | 4 |
Charney, DS | 8 |
Pyke, RE | 2 |
Nagy, LM | 1 |
Krystal, JH | 1 |
Söderpalm, B | 1 |
Ciccone, PE | 1 |
Clancy, J | 2 |
Coryell, WH | 2 |
Crowe, RR | 2 |
Chaudhry, DR | 1 |
Domingo, DV | 1 |
Heninger, GR | 6 |
Elliott, RL | 1 |
Thomas, BJ | 1 |
Strahan, A | 1 |
Rosenthal, J | 1 |
Kaswan, M | 1 |
Winston, A | 1 |
Perry, PJ | 1 |
Yamada, T | 1 |
Gabel, J | 1 |
Pöldinger, W | 1 |
Uhde, TW | 2 |
Post, RM | 1 |
Fyer, AJ | 2 |
Gorman, JM | 2 |
Campeas, R | 2 |
Levin, A | 2 |
Davies, SR | 1 |
Goetz, D | 2 |
Crocker, B | 1 |
Carr, DB | 2 |
Surman, OS | 2 |
Coleman, JH | 1 |
Jones, KJ | 2 |
Levine, PH | 1 |
Watkins, WD | 1 |
Newton, RE | 1 |
Marunycz, JD | 1 |
Alderdice, MT | 1 |
Napoliello, MJ | 1 |
Pecknold, JC | 6 |
Fleury, D | 1 |
Scrignar, CB | 1 |
Alexander, DD | 1 |
Hollister, LE | 1 |
Goodman, WK | 4 |
Price, LH | 1 |
Nesse, RM | 1 |
Cameron, OG | 1 |
Curtis, GC | 1 |
Lee, M | 1 |
Sonne, LM | 1 |
Wilcox, CS | 1 |
Ishiki, D | 1 |
Wilson, LG | 1 |
Hyde, TS | 1 |
Brotman, AW | 2 |
Eriksson, E | 1 |
Kahn, JP | 3 |
Puertollano, MA | 1 |
Schane, MD | 2 |
Castillo, A | 1 |
Sotillo, C | 1 |
Mariategui, J | 1 |
Reich, J | 2 |
Yates, W | 1 |
Coryell, W | 2 |
Beckett, A | 1 |
Fishman, SM | 2 |
Loke, J | 1 |
Redmond, DE | 1 |
Juergens, SM | 1 |
Morse, RM | 1 |
DuPont, RL | 3 |
Lesser, IM | 2 |
Rifkin, A | 3 |
Rubin, RT | 2 |
Lewis, CP | 1 |
Dugas, JE | 1 |
Mahoney, EM | 1 |
McNamara, M | 1 |
Goldstein, S | 2 |
Soto, S | 1 |
Howell, EF | 3 |
Kraus, M | 1 |
Montague-Clouse, J | 1 |
Patterson, JF | 1 |
Williams, J | 1 |
Strom, TB | 1 |
Coleman, J | 1 |
Mellman, TA | 1 |
Biraghi, M | 1 |
Fano, M | 1 |
Bernareggi, V | 1 |
Rifkin, B | 1 |
Kinch, M | 1 |
Aiken, B | 1 |
Quadrino, LM | 1 |
Edlund, MJ | 1 |
Swann, AC | 1 |
Clothier, J | 1 |
Puertollano, M | 1 |
Deicken, RF | 1 |
Miller, F | 1 |
Väisänen, E | 1 |
Jalkanen, E | 1 |
Sandberg, L | 1 |
Siris, SG | 1 |
Ries, RK | 1 |
Wittkowsky, AK | 1 |
O'Gorman, TW | 1 |
Stevenson, E | 1 |
Topol, P | 1 |
Lawlor, BA | 1 |
Davies, SO | 1 |
Akiskal, HS | 1 |
Clinical Trials (5)
Trial Overview
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Efficacy and Safety Study of a IMSS Developed Phytopharmaceutical for the Treatment of Anxiety. Double Blind and Randomized Clinical Trial Controlled With Alprazolam[NCT03702803] | Phase 2 | 122 participants (Anticipated) | Interventional | 2016-03-16 | Recruiting | ||
The Effectiveness of Psychopharmacological Intervention Versus Cognitive Behavioural Couple Therapy and Their Combination in Perinatal Distressed Couples: A Randomized Clinical Trial[NCT06001021] | 80 participants (Anticipated) | Interventional | 2023-08-15 | Not yet recruiting | |||
[NCT00004373] | Phase 2 | 80 participants | Interventional | 1997-03-31 | Completed | ||
Early Pharmacological Intervention With Diazepam in the Emergency Room Setting to Prevent Posttraumatic Stress Disorder (PTSD).[NCT01221883] | Phase 4 | 40 participants (Anticipated) | Interventional | 2013-05-31 | Active, not recruiting | ||
The Role of Orexin in Human Panic Disorder[NCT02593682] | Phase 4 | 3 participants (Actual) | Interventional | 2016-05-31 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Reviews
33 reviews available for alprazolam and Anxiety Disorders
Article | Year |
---|---|
Pharmacotherapy of generalized anxiety disorder.
Topics: Algorithms; Alprazolam; Antidepressive Agents; Antidepressive Agents, Tricyclic; Anxiety Disorders; | 2002 |
Pharmacotherapy of generalized anxiety disorder.
Topics: Algorithms; Alprazolam; Antidepressive Agents; Antidepressive Agents, Tricyclic; Anxiety Disorders; | 2002 |
Anxiety associated with comorbid depression.
Topics: Adult; Algorithms; Alprazolam; Amitriptyline; Antidepressive Agents; Anxiety Disorders; Benzodiazepi | 2002 |
Anxiety associated with comorbid depression.
Topics: Adult; Algorithms; Alprazolam; Amitriptyline; Antidepressive Agents; Anxiety Disorders; Benzodiazepi | 2002 |
[Panic attacks and panic disorder. Checklist for the diagnosis].
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Antidepressive Age | 2003 |
[Panic attacks and panic disorder. Checklist for the diagnosis].
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Antidepressive Age | 2003 |
Clinical pharmacology, clinical efficacy, and behavioral toxicity of alprazolam: a review of the literature.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Anxiety Disorders; Automobile Driving; Behavior; Clinical | 2004 |
Clinical pharmacology, clinical efficacy, and behavioral toxicity of alprazolam: a review of the literature.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Anxiety Disorders; Automobile Driving; Behavior; Clinical | 2004 |
Diagnosis and treatment of mixed anxiety-depression in the elderly.
Topics: Adult; Age Factors; Aged; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents; Antidepressive Age | 1982 |
Diagnosis and treatment of mixed anxiety-depression in the elderly.
Topics: Adult; Age Factors; Aged; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents; Antidepressive Age | 1982 |
Alprazolam: a review of its pharmacodynamic properties and efficacy in the treatment of anxiety and depression.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Benzodiazepines; | 1984 |
Alprazolam: a review of its pharmacodynamic properties and efficacy in the treatment of anxiety and depression.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Benzodiazepines; | 1984 |
Psychopharmacology of the anxiety disorders.
Topics: Adrenergic beta-Antagonists; Adult; Agoraphobia; Alprazolam; Antidepressive Agents, Tricyclic; Anxie | 1984 |
Psychopharmacology of the anxiety disorders.
Topics: Adrenergic beta-Antagonists; Adult; Agoraphobia; Alprazolam; Antidepressive Agents, Tricyclic; Anxie | 1984 |
Atypical depression.
Topics: Alprazolam; Anxiety Disorders; Benzodiazepines; Bipolar Disorder; Character; Chronic Disease; Clinic | 1984 |
Atypical depression.
Topics: Alprazolam; Anxiety Disorders; Benzodiazepines; Bipolar Disorder; Character; Chronic Disease; Clinic | 1984 |
Anxiety in elderly patients. A comparison of azapirones and benzodiazepines.
Topics: Aged; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Geriatric Assessment; Humans | 1994 |
Anxiety in elderly patients. A comparison of azapirones and benzodiazepines.
Topics: Aged; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Geriatric Assessment; Humans | 1994 |
Treating anxiety while minimizing abuse and dependence.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Clorazepate Dipotass | 1993 |
Treating anxiety while minimizing abuse and dependence.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Clorazepate Dipotass | 1993 |
Alprazolam pharmacokinetics, metabolism, and plasma levels: clinical implications.
Topics: Alprazolam; Anxiety Disorders; Biotransformation; Clinical Trials as Topic; Cytochrome P-450 Enzyme | 1993 |
Alprazolam pharmacokinetics, metabolism, and plasma levels: clinical implications.
Topics: Alprazolam; Anxiety Disorders; Biotransformation; Clinical Trials as Topic; Cytochrome P-450 Enzyme | 1993 |
A comparison of the safety and efficacy of alprazolam versus other agents in the treatment of anxiety, panic, and depression: a review of the literature.
Topics: Alprazolam; Antidepressive Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Clinical Trials as | 1993 |
A comparison of the safety and efficacy of alprazolam versus other agents in the treatment of anxiety, panic, and depression: a review of the literature.
Topics: Alprazolam; Antidepressive Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Clinical Trials as | 1993 |
Memory, benzodiazepines, and anxiety: integration of theoretical and clinical perspectives.
Topics: Alprazolam; Amnesia; Anxiety Disorders; Benzodiazepines; Dose-Response Relationship, Drug; Humans; M | 1993 |
Memory, benzodiazepines, and anxiety: integration of theoretical and clinical perspectives.
Topics: Alprazolam; Amnesia; Anxiety Disorders; Benzodiazepines; Dose-Response Relationship, Drug; Humans; M | 1993 |
Stress, neuropsychiatric disorders and immunological effects exerted by benzodiazepines.
Topics: Adjuvants, Immunologic; Alprazolam; Animals; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines | 1998 |
Stress, neuropsychiatric disorders and immunological effects exerted by benzodiazepines.
Topics: Adjuvants, Immunologic; Alprazolam; Animals; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines | 1998 |
Xanax: pros and cons.
Topics: Adult; Alprazolam; Anxiety Disorders; Depressive Disorder; Female; Humans; Panic Disorder; Stress Di | 1992 |
Xanax: pros and cons.
Topics: Adult; Alprazolam; Anxiety Disorders; Depressive Disorder; Female; Humans; Panic Disorder; Stress Di | 1992 |
Validation criteria for panic disorder as a nosological entity.
Topics: Alprazolam; Anxiety Disorders; Depressive Disorder; Humans; Imipramine; Panic; Psychiatric Status Ra | 1991 |
Validation criteria for panic disorder as a nosological entity.
Topics: Alprazolam; Anxiety Disorders; Depressive Disorder; Humans; Imipramine; Panic; Psychiatric Status Ra | 1991 |
Long-term management of panic disorder.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Clinical Trials as Topic; Clonazepam; Drug Toler | 1990 |
Long-term management of panic disorder.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Clinical Trials as Topic; Clonazepam; Drug Toler | 1990 |
High-potency benzodiazepines for short-term management of panic disorder: the U.S. experience.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Clinical Trials as Topic; Clonazepam; Fear; Huma | 1990 |
High-potency benzodiazepines for short-term management of panic disorder: the U.S. experience.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Clinical Trials as Topic; Clonazepam; Fear; Huma | 1990 |
Efficacy of benzodiazepines in panic disorder and agoraphobia.
Topics: Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Arousal; Humans; Panic | 1990 |
Efficacy of benzodiazepines in panic disorder and agoraphobia.
Topics: Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Arousal; Humans; Panic | 1990 |
Depression and panic anxiety: the effect of depressive co-morbidity on response to drug treatment of patients with panic disorder and agoraphobia.
Topics: Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Depressive Disorder; Humans; Panic | 1990 |
Depression and panic anxiety: the effect of depressive co-morbidity on response to drug treatment of patients with panic disorder and agoraphobia.
Topics: Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Depressive Disorder; Humans; Panic | 1990 |
Short-acting versus long-acting benzodiazepines: discontinuation effects in panic disorders.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Diazepam; Drug Administration Schedule; Humans; | 1990 |
Short-acting versus long-acting benzodiazepines: discontinuation effects in panic disorders.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Diazepam; Drug Administration Schedule; Humans; | 1990 |
A review of the psychopharmacology of panic disorder: individual differences and non specific factors.
Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Combined Modality Therapy; Humans; Imipramine; Panic; Ph | 1991 |
A review of the psychopharmacology of panic disorder: individual differences and non specific factors.
Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Combined Modality Therapy; Humans; Imipramine; Panic; Ph | 1991 |
Panic disorder: a treatment update.
Topics: Alprazolam; Antidepressive Agents, Tricyclic; Anxiety Disorders; Benzodiazepines; Humans; Monoamine | 1991 |
Panic disorder: a treatment update.
Topics: Alprazolam; Antidepressive Agents, Tricyclic; Anxiety Disorders; Benzodiazepines; Humans; Monoamine | 1991 |
Treatment of panic and agoraphobia. An integrative review.
Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Behavior Therapy; Bibliographies as Topic; Clinical Tria | 1990 |
Treatment of panic and agoraphobia. An integrative review.
Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Behavior Therapy; Bibliographies as Topic; Clinical Tria | 1990 |
Managing long-term therapy for panic disorder.
Topics: Alprazolam; Antidepressive Agents, Tricyclic; Anxiety Disorders; Benzodiazepines; Clinical Trials as | 1990 |
Managing long-term therapy for panic disorder.
Topics: Alprazolam; Antidepressive Agents, Tricyclic; Anxiety Disorders; Benzodiazepines; Clinical Trials as | 1990 |
Continuation treatment of panic disorder with high-potency benzodiazepines.
Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Behavior Therapy; Benzodiazepines; Clonazepam; Humans; P | 1990 |
Continuation treatment of panic disorder with high-potency benzodiazepines.
Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Behavior Therapy; Benzodiazepines; Clonazepam; Humans; P | 1990 |
Pharmacology of the benzodiazepines; with special emphasis on alprazolam.
Topics: Alprazolam; Animals; Anxiety Disorders; Benzodiazepines; Drug Tolerance; Humans; Rats; Receptors, GA | 1987 |
Pharmacology of the benzodiazepines; with special emphasis on alprazolam.
Topics: Alprazolam; Animals; Anxiety Disorders; Benzodiazepines; Drug Tolerance; Humans; Rats; Receptors, GA | 1987 |
Monoamine oxidase inhibitors and alprazolam in the treatment of panic disorder and agoraphobia.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Cheese; Diet; Drug-Related Side | 1985 |
Monoamine oxidase inhibitors and alprazolam in the treatment of panic disorder and agoraphobia.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Cheese; Diet; Drug-Related Side | 1985 |
Generalized anxiety disorder.
Topics: Adrenergic beta-Antagonists; Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents, Tricyc | 1985 |
Generalized anxiety disorder.
Topics: Adrenergic beta-Antagonists; Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents, Tricyc | 1985 |
Review of the side-effect profile of buspirone.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Clinical Trials as T | 1986 |
Review of the side-effect profile of buspirone.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Clinical Trials as T | 1986 |
Pharmacotherapeutic considerations in anxiety disorders.
Topics: Agoraphobia; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Anxiety Disorders; B | 1986 |
Pharmacotherapeutic considerations in anxiety disorders.
Topics: Agoraphobia; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Anxiety Disorders; B | 1986 |
Rebound anxiety in panic disorder patients treated with shorter-acting benzodiazepines.
Topics: Acute Disease; Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Clonazepam; Fear; Female; | 1987 |
Rebound anxiety in panic disorder patients treated with shorter-acting benzodiazepines.
Topics: Acute Disease; Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Clonazepam; Fear; Female; | 1987 |
Brain neurotransmission in panic disorder.
Topics: Alprazolam; Antidepressive Agents; Anxiety Disorders; Brain Chemistry; Fear; Humans; Neurotransmitte | 1987 |
Brain neurotransmission in panic disorder.
Topics: Alprazolam; Antidepressive Agents; Anxiety Disorders; Brain Chemistry; Fear; Humans; Neurotransmitte | 1987 |
Trials
113 trials available for alprazolam and Anxiety Disorders
Article | Year |
---|---|
Galphimine-B Standardized Extract versus Alprazolam in Patients with Generalized Anxiety Disorder: A Ten-Week, Double-Blind, Randomized Clinical Trial.
Topics: Alprazolam; Anxiety Disorders; Double-Blind Method; Female; Galphimia; Humans; Male; Middle Aged; Pa | 2019 |
Galphimine-B Standardized Extract versus Alprazolam in Patients with Generalized Anxiety Disorder: A Ten-Week, Double-Blind, Randomized Clinical Trial.
Topics: Alprazolam; Anxiety Disorders; Double-Blind Method; Female; Galphimia; Humans; Male; Middle Aged; Pa | 2019 |
Anxiolytic effects of vestipitant in a sub-group of healthy volunteers known to be sensitive to CO2 challenge.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety; Anxiety Disorders; Benzodiazepines; Carbon Dioxide; | 2014 |
Anxiolytic effects of vestipitant in a sub-group of healthy volunteers known to be sensitive to CO2 challenge.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety; Anxiety Disorders; Benzodiazepines; Carbon Dioxide; | 2014 |
Impact of alprazolam in allostatic load and neurocognition of patients with anxiety disorders and chronic stress (GEMA): observational study protocol.
Topics: Adult; Aged; Allostasis; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Argentina; Female; Huma | 2015 |
Impact of alprazolam in allostatic load and neurocognition of patients with anxiety disorders and chronic stress (GEMA): observational study protocol.
Topics: Adult; Aged; Allostasis; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Argentina; Female; Huma | 2015 |
Temporal profile of brain response to alprazolam in patients with generalized anxiety disorder.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Brain; Brain Mapping; Double-Blind Method | 2015 |
Temporal profile of brain response to alprazolam in patients with generalized anxiety disorder.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Brain; Brain Mapping; Double-Blind Method | 2015 |
A comparison of the effects of a subtype selective and non-selective benzodiazepine receptor agonist in two CO(2) models of experimental human anxiety.
Topics: Administration, Inhalation; Adolescent; Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; C | 2009 |
A comparison of the effects of a subtype selective and non-selective benzodiazepine receptor agonist in two CO(2) models of experimental human anxiety.
Topics: Administration, Inhalation; Adolescent; Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; C | 2009 |
Development of a patient-reported assessment to identify placebo responders in a generalized anxiety disorder trial.
Topics: Adolescent; Adult; Aged; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Dose-Response Relations | 2009 |
Development of a patient-reported assessment to identify placebo responders in a generalized anxiety disorder trial.
Topics: Adolescent; Adult; Aged; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Dose-Response Relations | 2009 |
Switching from long-term benzodiazepine therapy to pregabalin in patients with generalized anxiety disorder: a double-blind, placebo-controlled trial.
Topics: Adult; Alprazolam; Anxiety Disorders; Cognition; Double-Blind Method; Female; gamma-Aminobutyric Aci | 2012 |
Switching from long-term benzodiazepine therapy to pregabalin in patients with generalized anxiety disorder: a double-blind, placebo-controlled trial.
Topics: Adult; Alprazolam; Anxiety Disorders; Cognition; Double-Blind Method; Female; gamma-Aminobutyric Aci | 2012 |
[Efficacy of alprazolam (xanax) in mental disorders in patients with left- and right hemispheric ischemic stroke].
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Brain Ischemia; Depressive Disorder; Female; Fun | 2004 |
[Efficacy of alprazolam (xanax) in mental disorders in patients with left- and right hemispheric ischemic stroke].
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Brain Ischemia; Depressive Disorder; Female; Fun | 2004 |
Alprazolam (Xanax, and others) revisited.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Cognitive Behavioral Therapy; Double-Blin | 2005 |
Alprazolam (Xanax, and others) revisited.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Cognitive Behavioral Therapy; Double-Blin | 2005 |
Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anticonvulsants; Anxiety Disorders; Dizziness; Double-Blind | 2005 |
Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anticonvulsants; Anxiety Disorders; Dizziness; Double-Blind | 2005 |
Effectiveness of a meditation-based stress management program as an adjunct to pharmacotherapy in patients with anxiety disorder.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Combined Modality Therapy; Fluvoxamine; Humans; | 2007 |
Effectiveness of a meditation-based stress management program as an adjunct to pharmacotherapy in patients with anxiety disorder.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Combined Modality Therapy; Fluvoxamine; Humans; | 2007 |
Anxiolytic efficacy of alprazolam compared to diazepam and placebo.
Topics: Adolescent; Adult; Aged; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Clinic | 1980 |
Anxiolytic efficacy of alprazolam compared to diazepam and placebo.
Topics: Adolescent; Adult; Aged; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Clinic | 1980 |
Multicenter double-blind efficacy and safety study comparing alprazolam, diazepam and placebo in clinically anxious patients.
Topics: Adolescent; Adult; Aged; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Clinic | 1981 |
Multicenter double-blind efficacy and safety study comparing alprazolam, diazepam and placebo in clinically anxious patients.
Topics: Adolescent; Adult; Aged; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Clinic | 1981 |
Recent advances in anxiolytic therapy.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Clinical Tria | 1981 |
Recent advances in anxiolytic therapy.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Clinical Tria | 1981 |
A controlled clinical trial of alprazolam for the treatment of anxiety.
Topics: Adult; Alprazolam; Ambulatory Care; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Clinica | 1983 |
A controlled clinical trial of alprazolam for the treatment of anxiety.
Topics: Adult; Alprazolam; Ambulatory Care; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Clinica | 1983 |
Alprazolam in clinically anxious patients with depressed mood.
Topics: Adolescent; Adult; Aged; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Depres | 1983 |
Alprazolam in clinically anxious patients with depressed mood.
Topics: Adolescent; Adult; Aged; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Depres | 1983 |
A double-blind study of alprazolam and lorazepam in the treatment of anxiety.
Topics: Adolescent; Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Clinical Tri | 1983 |
A double-blind study of alprazolam and lorazepam in the treatment of anxiety.
Topics: Adolescent; Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Clinical Tri | 1983 |
Alprazolam and amitryptyline: a double blind comparison of anxiolytic and anti-depressant activity.
Topics: Alprazolam; Amitriptyline; Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Benzodiaze | 1983 |
Alprazolam and amitryptyline: a double blind comparison of anxiolytic and anti-depressant activity.
Topics: Alprazolam; Amitriptyline; Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Benzodiaze | 1983 |
New concepts in benzodiazepine therapy: rebound anxiety and new indications for the more potent benzodiazepines.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Bipolar Disorder; Bromazepam; C | 1983 |
New concepts in benzodiazepine therapy: rebound anxiety and new indications for the more potent benzodiazepines.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Bipolar Disorder; Bromazepam; C | 1983 |
Alprazolam: a review of its pharmacodynamic properties and efficacy in the treatment of anxiety and depression.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Benzodiazepines; | 1984 |
Alprazolam: a review of its pharmacodynamic properties and efficacy in the treatment of anxiety and depression.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Benzodiazepines; | 1984 |
Alprazolam in the treatment of neurotic anxiety.
Topics: Adolescent; Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Clinical Tri | 1983 |
Alprazolam in the treatment of neurotic anxiety.
Topics: Adolescent; Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Clinical Tri | 1983 |
Alprazolam and diazepam in the treatment of generalized anxiety.
Topics: Adult; Aged; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Clinical Trials as | 1984 |
Alprazolam and diazepam in the treatment of generalized anxiety.
Topics: Adult; Aged; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Clinical Trials as | 1984 |
Atypical depression.
Topics: Alprazolam; Anxiety Disorders; Benzodiazepines; Bipolar Disorder; Character; Chronic Disease; Clinic | 1984 |
Atypical depression.
Topics: Alprazolam; Anxiety Disorders; Benzodiazepines; Bipolar Disorder; Character; Chronic Disease; Clinic | 1984 |
Double-blind comparison of alprazolam and diazepam for subchronic withdrawal from alcohol.
Topics: Adolescent; Adult; Aged; Alcoholism; Alprazolam; Anxiety Disorders; Benzodiazepines; Clinical Trials | 1981 |
Double-blind comparison of alprazolam and diazepam for subchronic withdrawal from alcohol.
Topics: Adolescent; Adult; Aged; Alcoholism; Alprazolam; Anxiety Disorders; Benzodiazepines; Clinical Trials | 1981 |
Effects of alprazolam on glucose regulation in diabetes. Results of double-blind, placebo-controlled trial.
Topics: Adult; Alprazolam; Analysis of Variance; Anti-Anxiety Agents; Anxiety; Anxiety Disorders; Blood Gluc | 1995 |
Effects of alprazolam on glucose regulation in diabetes. Results of double-blind, placebo-controlled trial.
Topics: Adult; Alprazolam; Analysis of Variance; Anti-Anxiety Agents; Anxiety; Anxiety Disorders; Blood Gluc | 1995 |
Comparison of the efficacy, safety and withdrawal of alpidem and alprazolam in anxious patients.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Dose-Response Relationship, Drug; Double- | 1994 |
Comparison of the efficacy, safety and withdrawal of alpidem and alprazolam in anxious patients.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Dose-Response Relationship, Drug; Double- | 1994 |
Relationship of panic, anticipatory anxiety, agoraphobia and global improvement in panic disorder with agoraphobia treated with alprazolam and exposure.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Arousal; Combined Modality Therapy; Desensitizati | 1994 |
Relationship of panic, anticipatory anxiety, agoraphobia and global improvement in panic disorder with agoraphobia treated with alprazolam and exposure.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Arousal; Combined Modality Therapy; Desensitizati | 1994 |
Alprazolam withdrawal in patients with panic disorder and generalized anxiety disorder: vulnerability and effect of carbamazepine.
Topics: Adult; Alprazolam; Anxiety Disorders; Carbamazepine; Double-Blind Method; Drug Administration Schedu | 1994 |
Alprazolam withdrawal in patients with panic disorder and generalized anxiety disorder: vulnerability and effect of carbamazepine.
Topics: Adult; Alprazolam; Anxiety Disorders; Carbamazepine; Double-Blind Method; Drug Administration Schedu | 1994 |
Upjohn answers Consumer Reports.
Topics: Adverse Drug Reaction Reporting Systems; Alprazolam; Anxiety Disorders; Drug Industry; Humans; Panic | 1993 |
Upjohn answers Consumer Reports.
Topics: Adverse Drug Reaction Reporting Systems; Alprazolam; Anxiety Disorders; Drug Industry; Humans; Panic | 1993 |
Maintenance drug treatment of panic disorder. I. Results of a prospective, placebo-controlled comparison of alprazolam and imipramine.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Dose-Response Relationship, Drug; Double-Blind Me | 1993 |
Maintenance drug treatment of panic disorder. I. Results of a prospective, placebo-controlled comparison of alprazolam and imipramine.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Dose-Response Relationship, Drug; Double-Blind Me | 1993 |
Alprazolam-reinforced medication use in outpatients with anxiety.
Topics: Adult; Alprazolam; Analysis of Variance; Anti-Anxiety Agents; Anxiety Disorders; Behavior, Addictive | 1997 |
Alprazolam-reinforced medication use in outpatients with anxiety.
Topics: Adult; Alprazolam; Analysis of Variance; Anti-Anxiety Agents; Anxiety Disorders; Behavior, Addictive | 1997 |
A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group.
Topics: Adolescent; Adult; Aged; Alprazolam; Ambulatory Care; Anti-Anxiety Agents; Anxiety Disorders; Carbol | 1997 |
A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group.
Topics: Adolescent; Adult; Aged; Alprazolam; Ambulatory Care; Anti-Anxiety Agents; Anxiety Disorders; Carbol | 1997 |
Subjective experience and attitudes towards participation in clinical trials among patients with anxiety disorders.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Female; Humans; Male; Panic Disorder; Pat | 1997 |
Subjective experience and attitudes towards participation in clinical trials among patients with anxiety disorders.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Female; Humans; Male; Panic Disorder; Pat | 1997 |
Medication side effects in anxious patients: negative placebo responses?
Topics: Acute Disease; Adult; Alprazolam; Anxiety Disorders; Delayed-Action Preparations; Dose-Response Rela | 1998 |
Medication side effects in anxious patients: negative placebo responses?
Topics: Acute Disease; Adult; Alprazolam; Anxiety Disorders; Delayed-Action Preparations; Dose-Response Rela | 1998 |
Treatment of recent trauma survivors with benzodiazepines: a prospective study.
Topics: Alprazolam; Anxiety Disorders; Arousal; Benzodiazepines; Clonazepam; Follow-Up Studies; Heart Rate; | 1996 |
Treatment of recent trauma survivors with benzodiazepines: a prospective study.
Topics: Alprazolam; Anxiety Disorders; Arousal; Benzodiazepines; Clonazepam; Follow-Up Studies; Heart Rate; | 1996 |
Saliva level of free 3-methoxy-4-hydroxyphenylglycol in psychiatric outpatients with anxiety.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Female; Humans; Male; Methoxyhydroxypheny | 1998 |
Saliva level of free 3-methoxy-4-hydroxyphenylglycol in psychiatric outpatients with anxiety.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Female; Humans; Male; Methoxyhydroxypheny | 1998 |
Predictors of individual differences in alprazolam self-medication.
Topics: Adult; Affect; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Double-Blind Method; Female; Huma | 1999 |
Predictors of individual differences in alprazolam self-medication.
Topics: Adult; Affect; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Double-Blind Method; Female; Huma | 1999 |
Prior benzodiazepine exposure and benzodiazepine treatment outcome.
Topics: Alprazolam; Anxiety Disorders; Benzodiazepines; Diazepam; Dose-Response Relationship, Drug; Double-B | 2000 |
Prior benzodiazepine exposure and benzodiazepine treatment outcome.
Topics: Alprazolam; Anxiety Disorders; Benzodiazepines; Diazepam; Dose-Response Relationship, Drug; Double-B | 2000 |
Effects of repeated ingestion of grapefruit juice on the single and multiple oral-dose pharmacokinetics and pharmacodynamics of alprazolam.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Beverages; Citrus; Cross-Over Studies; Cy | 2000 |
Effects of repeated ingestion of grapefruit juice on the single and multiple oral-dose pharmacokinetics and pharmacodynamics of alprazolam.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Beverages; Citrus; Cross-Over Studies; Cy | 2000 |
Opipramol for the treatment of generalized anxiety disorder: a placebo-controlled trial including an alprazolam-treated group.
Topics: Adolescent; Adult; Aged; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Anxiety | 2001 |
Opipramol for the treatment of generalized anxiety disorder: a placebo-controlled trial including an alprazolam-treated group.
Topics: Adolescent; Adult; Aged; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Anxiety | 2001 |
Drug treatment of panic disorder. Reply to comment by Marks and associates.
Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Cross-Cultural Comparison; Dose-Response Relationship, D | 1992 |
Drug treatment of panic disorder. Reply to comment by Marks and associates.
Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Cross-Cultural Comparison; Dose-Response Relationship, D | 1992 |
Effect of acute and chronic benzodiazepines on plasma GABA in anxious patients and controls.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Diazepam; gamma-Aminobutyric Acid; Humans | 1992 |
Effect of acute and chronic benzodiazepines on plasma GABA in anxious patients and controls.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Diazepam; gamma-Aminobutyric Acid; Humans | 1992 |
Clinical, cognitive, and neurophysiological effects of alprazolam in children and adolescents with overanxious and avoidant disorders.
Topics: Adolescent; Alprazolam; Anxiety Disorders; Arousal; Cerebral Cortex; Child; Double-Blind Method; Ele | 1992 |
Clinical, cognitive, and neurophysiological effects of alprazolam in children and adolescents with overanxious and avoidant disorders.
Topics: Adolescent; Alprazolam; Anxiety Disorders; Arousal; Cerebral Cortex; Child; Double-Blind Method; Ele | 1992 |
An open label trial of alprazolam in comorbid irritable bowel syndrome and generalized anxiety disorder.
Topics: Alprazolam; Anxiety Disorders; Colonic Diseases, Functional; Comorbidity; Female; Humans; Male; Midd | 1991 |
An open label trial of alprazolam in comorbid irritable bowel syndrome and generalized anxiety disorder.
Topics: Alprazolam; Anxiety Disorders; Colonic Diseases, Functional; Comorbidity; Female; Humans; Male; Midd | 1991 |
Alprazolam versus buspirone in the treatment of outpatients with generalized anxiety disorder.
Topics: Adolescent; Adult; Aged; Alprazolam; Anxiety Disorders; Buspirone; Double-Blind Method; Female; Huma | 1991 |
Alprazolam versus buspirone in the treatment of outpatients with generalized anxiety disorder.
Topics: Adolescent; Adult; Aged; Alprazolam; Anxiety Disorders; Buspirone; Double-Blind Method; Female; Huma | 1991 |
Chronology of panic and avoidance, age of onset in panic disorder, and prediction of treatment response. A report from the Cross-National Collaborative Panic Study.
Topics: Adult; Age Factors; Alprazolam; Anxiety Disorders; Arousal; Drug Administration Schedule; Female; Hu | 1991 |
Chronology of panic and avoidance, age of onset in panic disorder, and prediction of treatment response. A report from the Cross-National Collaborative Panic Study.
Topics: Adult; Age Factors; Alprazolam; Anxiety Disorders; Arousal; Drug Administration Schedule; Female; Hu | 1991 |
Subtyping panic disorder by major depression and avoidance behaviour and the response to active treatment.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Depressive Disorder; Double-Blind Method; Female; | 1991 |
Subtyping panic disorder by major depression and avoidance behaviour and the response to active treatment.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Depressive Disorder; Double-Blind Method; Female; | 1991 |
Efficacy and safety of alprazolam, imipramine and placebo in treating panic disorder. A Scandinavian multicenter study.
Topics: Adolescent; Adult; Alprazolam; Anxiety Disorders; Arousal; Child; Double-Blind Method; Female; Human | 1991 |
Efficacy and safety of alprazolam, imipramine and placebo in treating panic disorder. A Scandinavian multicenter study.
Topics: Adolescent; Adult; Alprazolam; Anxiety Disorders; Arousal; Child; Double-Blind Method; Female; Human | 1991 |
A trend analysis of changes during treatment of panic disorder with alprazolam and imipramine.
Topics: Alprazolam; Anxiety Disorders; Arousal; Humans; Imipramine; Panic; Personality Tests; Psychiatric St | 1991 |
A trend analysis of changes during treatment of panic disorder with alprazolam and imipramine.
Topics: Alprazolam; Anxiety Disorders; Arousal; Humans; Imipramine; Panic; Personality Tests; Psychiatric St | 1991 |
Characteristics of panic disorder patients responding to placebo.
Topics: Alprazolam; Anxiety Disorders; Double-Blind Method; Drug Evaluation; Female; Humans; Imipramine; Mal | 1991 |
Characteristics of panic disorder patients responding to placebo.
Topics: Alprazolam; Anxiety Disorders; Double-Blind Method; Drug Evaluation; Female; Humans; Imipramine; Mal | 1991 |
Secondary depression in panic disorder: an indicator of severity with a weak effect on outcome in alprazolam and imipramine treatment.
Topics: Alprazolam; Anxiety Disorders; Depressive Disorder; Double-Blind Method; Follow-Up Studies; Humans; | 1991 |
Secondary depression in panic disorder: an indicator of severity with a weak effect on outcome in alprazolam and imipramine treatment.
Topics: Alprazolam; Anxiety Disorders; Depressive Disorder; Double-Blind Method; Follow-Up Studies; Humans; | 1991 |
Alprazolam, imipramine and placebo treatment of panic disorder: predicting therapeutic response.
Topics: Adult; Alprazolam; Anxiety Disorders; Double-Blind Method; Female; Follow-Up Studies; Humans; Imipra | 1991 |
Alprazolam, imipramine and placebo treatment of panic disorder: predicting therapeutic response.
Topics: Adult; Alprazolam; Anxiety Disorders; Double-Blind Method; Female; Follow-Up Studies; Humans; Imipra | 1991 |
Alprazolam and oxazepam in the treatment of anxious out-patients with depressive symptoms: a double-blind multicenter study.
Topics: Adult; Alprazolam; Anxiety Disorders; Depression; Double-Blind Method; Humans; Middle Aged; Oxazepam | 1991 |
Alprazolam and oxazepam in the treatment of anxious out-patients with depressive symptoms: a double-blind multicenter study.
Topics: Adult; Alprazolam; Anxiety Disorders; Depression; Double-Blind Method; Humans; Middle Aged; Oxazepam | 1991 |
Lactate vulnerability after alprazolam versus placebo treatment of panic disorder.
Topics: Adult; Alprazolam; Anxiety Disorders; Arousal; Depressive Disorder; Dose-Response Relationship, Drug | 1991 |
Lactate vulnerability after alprazolam versus placebo treatment of panic disorder.
Topics: Adult; Alprazolam; Anxiety Disorders; Arousal; Depressive Disorder; Dose-Response Relationship, Drug | 1991 |
Surreptitious drug use by patients in a panic disorder study.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Clinical Trials as Topic; Double-Blind Me | 1990 |
Surreptitious drug use by patients in a panic disorder study.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Clinical Trials as Topic; Double-Blind Me | 1990 |
Long-term management of panic disorder.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Clinical Trials as Topic; Clonazepam; Drug Toler | 1990 |
Long-term management of panic disorder.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Clinical Trials as Topic; Clonazepam; Drug Toler | 1990 |
High-potency benzodiazepines for short-term management of panic disorder: the U.S. experience.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Clinical Trials as Topic; Clonazepam; Fear; Huma | 1990 |
High-potency benzodiazepines for short-term management of panic disorder: the U.S. experience.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Clinical Trials as Topic; Clonazepam; Fear; Huma | 1990 |
Efficacy of benzodiazepines in panic disorder and agoraphobia.
Topics: Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Arousal; Humans; Panic | 1990 |
Efficacy of benzodiazepines in panic disorder and agoraphobia.
Topics: Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Arousal; Humans; Panic | 1990 |
Depression and panic anxiety: the effect of depressive co-morbidity on response to drug treatment of patients with panic disorder and agoraphobia.
Topics: Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Depressive Disorder; Humans; Panic | 1990 |
Depression and panic anxiety: the effect of depressive co-morbidity on response to drug treatment of patients with panic disorder and agoraphobia.
Topics: Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Depressive Disorder; Humans; Panic | 1990 |
Short-acting versus long-acting benzodiazepines: discontinuation effects in panic disorders.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Diazepam; Drug Administration Schedule; Humans; | 1990 |
Short-acting versus long-acting benzodiazepines: discontinuation effects in panic disorders.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Diazepam; Drug Administration Schedule; Humans; | 1990 |
Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder.
Topics: Adult; Alprazolam; Anxiety Disorders; Ataxia; Clonazepam; Double-Blind Method; Female; Humans; Male; | 1991 |
Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder.
Topics: Adult; Alprazolam; Anxiety Disorders; Ataxia; Clonazepam; Double-Blind Method; Female; Humans; Male; | 1991 |
How "blind" are double-blind studies?
Topics: Adult; Alprazolam; Anxiety Disorders; Double-Blind Method; Female; Humans; Imipramine; Male; Middle | 1991 |
How "blind" are double-blind studies?
Topics: Adult; Alprazolam; Anxiety Disorders; Double-Blind Method; Female; Humans; Imipramine; Male; Middle | 1991 |
Patients with panic disorder unaccompanied by depression improve with alprazolam and imipramine treatment.
Topics: Adult; Alprazolam; Anxiety Disorders; Comorbidity; Depressive Disorder; Double-Blind Method; Female; | 1991 |
Patients with panic disorder unaccompanied by depression improve with alprazolam and imipramine treatment.
Topics: Adult; Alprazolam; Anxiety Disorders; Comorbidity; Depressive Disorder; Double-Blind Method; Female; | 1991 |
Controlled discontinuation of benzodiazepine treatment for patients with panic disorder.
Topics: Adult; Alprazolam; Anxiety Disorders; Diazepam; Double-Blind Method; Female; Half-Life; Humans; Male | 1991 |
Controlled discontinuation of benzodiazepine treatment for patients with panic disorder.
Topics: Adult; Alprazolam; Anxiety Disorders; Diazepam; Double-Blind Method; Female; Half-Life; Humans; Male | 1991 |
A randomized clinical trial of alprazolam versus progressive muscle relaxation in cancer patients with anxiety and depressive symptoms.
Topics: Adult; Aged; Alprazolam; Anxiety Disorders; Behavior Therapy; Depression; Female; Humans; Male; Midd | 1991 |
A randomized clinical trial of alprazolam versus progressive muscle relaxation in cancer patients with anxiety and depressive symptoms.
Topics: Adult; Aged; Alprazolam; Anxiety Disorders; Behavior Therapy; Depression; Female; Humans; Male; Midd | 1991 |
Alprazolam levels and response in panic disorder: preliminary results.
Topics: Adolescent; Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Chromatography, Gas; Female; Humans; | 1991 |
Alprazolam levels and response in panic disorder: preliminary results.
Topics: Adolescent; Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Chromatography, Gas; Female; Humans; | 1991 |
Effect of alprazolam on depression in panic disorder.
Topics: Adolescent; Adult; Aged; Alprazolam; Anxiety Disorders; Depressive Disorder; Dose-Response Relations | 1991 |
Effect of alprazolam on depression in panic disorder.
Topics: Adolescent; Adult; Aged; Alprazolam; Anxiety Disorders; Depressive Disorder; Dose-Response Relations | 1991 |
Treatment of panic and agoraphobia. An integrative review.
Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Behavior Therapy; Bibliographies as Topic; Clinical Tria | 1990 |
Treatment of panic and agoraphobia. An integrative review.
Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Behavior Therapy; Bibliographies as Topic; Clinical Tria | 1990 |
Self- and observer assessment in anxiolytic drug trials: a comparison of their validity.
Topics: Adult; Alprazolam; Anxiety Disorders; Double-Blind Method; Humans; Imipramine; Middle Aged; Panic; P | 1990 |
Self- and observer assessment in anxiolytic drug trials: a comparison of their validity.
Topics: Adult; Alprazolam; Anxiety Disorders; Double-Blind Method; Humans; Imipramine; Middle Aged; Panic; P | 1990 |
Consistencies and discrepancies in self- and observer-rated anxiety scales. A comparison between the self- and observer-rated Marks-Sheehan scales.
Topics: Adult; Alprazolam; Anxiety Disorders; Double-Blind Method; Humans; Imipramine; Middle Aged; Panic; P | 1990 |
Consistencies and discrepancies in self- and observer-rated anxiety scales. A comparison between the self- and observer-rated Marks-Sheehan scales.
Topics: Adult; Alprazolam; Anxiety Disorders; Double-Blind Method; Humans; Imipramine; Middle Aged; Panic; P | 1990 |
Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder: results of a double-blind, placebo-controlled trial.
Topics: Adult; Agoraphobia; Alprazolam; Analysis of Variance; Anxiety; Anxiety Disorders; Depression; Disabi | 1990 |
Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder: results of a double-blind, placebo-controlled trial.
Topics: Adult; Agoraphobia; Alprazolam; Analysis of Variance; Anxiety; Anxiety Disorders; Depression; Disabi | 1990 |
Patterns of response during placebo treatment of panic disorder.
Topics: Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Double-Blind Method; Fear; Follow-Up Studie | 1990 |
Patterns of response during placebo treatment of panic disorder.
Topics: Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Double-Blind Method; Fear; Follow-Up Studie | 1990 |
Antidepressant or antianxiety? A study of the efficacy of antidepressant medication.
Topics: Adult; Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Depressive Disorder; Desipramine; Dr | 1990 |
Antidepressant or antianxiety? A study of the efficacy of antidepressant medication.
Topics: Adult; Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Depressive Disorder; Desipramine; Dr | 1990 |
Concurrent use of buspirone in anxious patients during withdrawal from alprazolam therapy.
Topics: Adolescent; Adult; Aged; Alprazolam; Anxiety Disorders; Buspirone; Double-Blind Method; Drug Adminis | 1990 |
Concurrent use of buspirone in anxious patients during withdrawal from alprazolam therapy.
Topics: Adolescent; Adult; Aged; Alprazolam; Anxiety Disorders; Buspirone; Double-Blind Method; Drug Adminis | 1990 |
Comparative studies of pharmacotherapy for school refusal.
Topics: Adjustment Disorders; Adolescent; Alprazolam; Anxiety Disorders; Child; Depressive Disorder; Double- | 1990 |
Comparative studies of pharmacotherapy for school refusal.
Topics: Adjustment Disorders; Adolescent; Alprazolam; Anxiety Disorders; Child; Depressive Disorder; Double- | 1990 |
Characteristics of placebo response during long-term treatment of panic disorder.
Topics: Adult; Alprazolam; Anxiety Disorders; Double-Blind Method; Female; Humans; Longitudinal Studies; Mal | 1990 |
Characteristics of placebo response during long-term treatment of panic disorder.
Topics: Adult; Alprazolam; Anxiety Disorders; Double-Blind Method; Female; Humans; Longitudinal Studies; Mal | 1990 |
Drug treatment of panic disorder: early response to treatment as a predictor of final outcome.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Arousal; Double-Blind Method; Female; Humans; Imi | 1990 |
Drug treatment of panic disorder: early response to treatment as a predictor of final outcome.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Arousal; Double-Blind Method; Female; Humans; Imi | 1990 |
A comparison of alprazolam and behavior therapy in treatment of panic disorder.
Topics: Adolescent; Adult; Aged; Alprazolam; Analysis of Variance; Anxiety Disorders; Behavior Therapy; Chi- | 1990 |
A comparison of alprazolam and behavior therapy in treatment of panic disorder.
Topics: Adolescent; Adult; Aged; Alprazolam; Analysis of Variance; Anxiety Disorders; Behavior Therapy; Chi- | 1990 |
The relationship of alprazolam dose to steady-state plasma concentrations.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Dose-Response Relations | 1990 |
The relationship of alprazolam dose to steady-state plasma concentrations.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Dose-Response Relations | 1990 |
Long-term effects of alprazolam and imipramine on cerebrospinal fluid monoamine metabolites and neuropeptides in panic disorder.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; beta-Endorphin; Clinical Trials as Topic; Double- | 1989 |
Long-term effects of alprazolam and imipramine on cerebrospinal fluid monoamine metabolites and neuropeptides in panic disorder.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; beta-Endorphin; Clinical Trials as Topic; Double- | 1989 |
Pharmacotherapeutic treatment of panic disorder in patients presenting with chest pain.
Topics: Adult; Alprazolam; Anxiety Disorders; Chest Pain; Clinical Trials as Topic; Fear; Female; Humans; Ma | 1989 |
Pharmacotherapeutic treatment of panic disorder in patients presenting with chest pain.
Topics: Adult; Alprazolam; Anxiety Disorders; Chest Pain; Clinical Trials as Topic; Fear; Female; Humans; Ma | 1989 |
The 'efficacy' of alprazolam in panic disorder and agoraphobia: a critique of recent reports.
Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Double-Blind Method; Fear; Hum | 1989 |
The 'efficacy' of alprazolam in panic disorder and agoraphobia: a critique of recent reports.
Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Double-Blind Method; Fear; Hum | 1989 |
Etizolam in the treatment of generalized anxiety disorder associated with depressive symptoms.
Topics: Adult; Alprazolam; Anxiety Disorders; Consumer Behavior; Depression; Diazepam; Double-Blind Method; | 1989 |
Etizolam in the treatment of generalized anxiety disorder associated with depressive symptoms.
Topics: Adult; Alprazolam; Anxiety Disorders; Consumer Behavior; Depression; Diazepam; Double-Blind Method; | 1989 |
Benzodiazepine treatment of panic disorder: a comparison of alprazolam and lorazepam.
Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Double-Blind Method; Fear; Humans; Lorazepam; Panic; Ran | 1989 |
Benzodiazepine treatment of panic disorder: a comparison of alprazolam and lorazepam.
Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Double-Blind Method; Fear; Humans; Lorazepam; Panic; Ran | 1989 |
A case report of alprazolam-induced stuttering.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Depressive Disorder; Dos | 1985 |
A case report of alprazolam-induced stuttering.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Depressive Disorder; Dos | 1985 |
[Alprazolam vs. oxazepam in the treatment of anxious-neurotic patients].
Topics: Adult; Aged; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Clinical Trials as | 1985 |
[Alprazolam vs. oxazepam in the treatment of anxious-neurotic patients].
Topics: Adult; Aged; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Clinical Trials as | 1985 |
Alprazolam in the treatment of panic disorders.
Topics: Adult; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Clinical Tr | 1986 |
Alprazolam in the treatment of panic disorders.
Topics: Adult; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Clinical Tr | 1986 |
Neuroendocrine correlates of lactate-induced anxiety and their response to chronic alprazolam therapy.
Topics: Adolescent; Adult; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; | 1986 |
Neuroendocrine correlates of lactate-induced anxiety and their response to chronic alprazolam therapy.
Topics: Adolescent; Adult; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; | 1986 |
Review of the side-effect profile of buspirone.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Clinical Trials as T | 1986 |
Review of the side-effect profile of buspirone.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Clinical Trials as T | 1986 |
Ineffectiveness of clonidine in the treatment of the benzodiazepine withdrawal syndrome: report of three cases.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Blood Pressure; Clinical | 1986 |
Ineffectiveness of clonidine in the treatment of the benzodiazepine withdrawal syndrome: report of three cases.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Blood Pressure; Clinical | 1986 |
[Alprazolam (Tafil) and bromazepam (Lexotan) in the treatment of anxiety. A randomized, double-blind comparison in psychiatric outpatients].
Topics: Adolescent; Adult; Aged; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Bromaz | 1986 |
[Alprazolam (Tafil) and bromazepam (Lexotan) in the treatment of anxiety. A randomized, double-blind comparison in psychiatric outpatients].
Topics: Adolescent; Adult; Aged; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Bromaz | 1986 |
Low-sedation potential of buspirone compared with alprazolam and lorazepam in the treatment of anxious patients: a double-blind study.
Topics: Adolescent; Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; C | 1986 |
Low-sedation potential of buspirone compared with alprazolam and lorazepam in the treatment of anxious patients: a double-blind study.
Topics: Adolescent; Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; C | 1986 |
Effect of alprazolam and diazepam on anxiety and panic attacks in panic disorder: a controlled study.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Clinical Trials as Topic | 1986 |
Effect of alprazolam and diazepam on anxiety and panic attacks in panic disorder: a controlled study.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Clinical Trials as Topic | 1986 |
Alprazolam compared to clobazam and placebo in anxious outpatients.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Benzodiazepinones; Clini | 1987 |
Alprazolam compared to clobazam and placebo in anxious outpatients.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Benzodiazepinones; Clini | 1987 |
Differential effects of alprazolam and imipramine in generalized anxiety disorder: somatic versus psychic symptoms.
Topics: Adult; Alprazolam; Analysis of Variance; Anxiety Disorders; Clinical Trials as Topic; Double-Blind M | 1988 |
Differential effects of alprazolam and imipramine in generalized anxiety disorder: somatic versus psychic symptoms.
Topics: Adult; Alprazolam; Analysis of Variance; Anxiety Disorders; Clinical Trials as Topic; Double-Blind M | 1988 |
Placebo response in panic disorder.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Dexamethasone; Diazepam | 1988 |
Placebo response in panic disorder.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Dexamethasone; Diazepam | 1988 |
Carbon dioxide sensitivity in panic anxiety. Ventilatory and anxiogenic response to carbon dioxide in healthy subjects and patients with panic anxiety before and after alprazolam treatment.
Topics: Adult; Alprazolam; Anxiety Disorders; Benzodiazepines; Brain; Carbon Dioxide; Chemoreceptor Cells; F | 1986 |
Carbon dioxide sensitivity in panic anxiety. Ventilatory and anxiogenic response to carbon dioxide in healthy subjects and patients with panic anxiety before and after alprazolam treatment.
Topics: Adult; Alprazolam; Anxiety Disorders; Benzodiazepines; Brain; Carbon Dioxide; Chemoreceptor Cells; F | 1986 |
Overview of the Cross-National Collaborative Panic Study.
Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Fear; Goals; Humans; Imipramin | 1988 |
Overview of the Cross-National Collaborative Panic Study.
Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Fear; Goals; Humans; Imipramin | 1988 |
Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment.
Topics: Adolescent; Adult; Aged; Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Double-Blind Metho | 1988 |
Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment.
Topics: Adolescent; Adult; Aged; Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Double-Blind Metho | 1988 |
Secondary depression in panic disorder and agoraphobia. I. Frequency, severity, and response to treatment.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Depressive Disorder; Do | 1988 |
Secondary depression in panic disorder and agoraphobia. I. Frequency, severity, and response to treatment.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Depressive Disorder; Do | 1988 |
Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. III. Discontinuation effects.
Topics: Adult; Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Drug Administration Schedule; Fear; | 1988 |
Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. III. Discontinuation effects.
Topics: Adult; Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Drug Administration Schedule; Fear; | 1988 |
Misrepresenting uncontrolled clinical observations as "research".
Topics: Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Fear; Humans; Panic; Research Design; Retro | 1987 |
Misrepresenting uncontrolled clinical observations as "research".
Topics: Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Fear; Humans; Panic; Research Design; Retro | 1987 |
Clonazepam versus alprazolam in the treatment of panic disorder: interim analysis of data from a prospective, double-blind, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Clonazepam; Double | 1987 |
Clonazepam versus alprazolam in the treatment of panic disorder: interim analysis of data from a prospective, double-blind, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Clonazepam; Double | 1987 |
Recent developments in the treatment of panic disorder.
Topics: Alprazolam; Antidepressive Agents; Anxiety Disorders; Behavior Therapy; Benzodiazepines; Clinical Tr | 1987 |
Recent developments in the treatment of panic disorder.
Topics: Alprazolam; Antidepressive Agents; Anxiety Disorders; Behavior Therapy; Benzodiazepines; Clinical Tr | 1987 |
Alprazolam effects in children with anxiety disorders.
Topics: Adolescent; Alprazolam; Anxiety Disorders; Child; Clinical Trials as Topic; Female; Humans; Male; Ps | 1987 |
Alprazolam effects in children with anxiety disorders.
Topics: Adolescent; Alprazolam; Anxiety Disorders; Child; Clinical Trials as Topic; Female; Humans; Male; Ps | 1987 |
Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Ataxia; Chemical and Drug Induced Liver Injury; F | 1988 |
Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Ataxia; Chemical and Drug Induced Liver Injury; F | 1988 |
Immunological response to stress in agoraphobia and panic attacks.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Benzodiazepines; Clinical Trials as Topic; Fear; | 1986 |
Immunological response to stress in agoraphobia and panic attacks.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Benzodiazepines; Clinical Trials as Topic; Fear; | 1986 |
Withdrawal syndrome with gradual tapering of alprazolam.
Topics: Adult; Alprazolam; Anxiety Disorders; Bipolar Disorder; Clinical Trials as Topic; Double-Blind Metho | 1986 |
Withdrawal syndrome with gradual tapering of alprazolam.
Topics: Adult; Alprazolam; Anxiety Disorders; Bipolar Disorder; Clinical Trials as Topic; Double-Blind Metho | 1986 |
[Multicenter clinical experimentation with alprazolam].
Topics: Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Depression; Female; Humans; Male; Panic | 1986 |
[Multicenter clinical experimentation with alprazolam].
Topics: Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Depression; Female; Humans; Male; Panic | 1986 |
Drug treatment of panic disorder: the comparative efficacy of imipramine, alprazolam, and trazodone.
Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Fear; Humans; Imipramine; Pani | 1986 |
Drug treatment of panic disorder: the comparative efficacy of imipramine, alprazolam, and trazodone.
Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Fear; Humans; Imipramine; Pani | 1986 |
A double-blind study of alprazolam and oxazepam in the treatment of anxiety.
Topics: Adult; Alprazolam; Anxiety Disorders; Depression; Double-Blind Method; Female; Humans; Male; Middle | 1987 |
A double-blind study of alprazolam and oxazepam in the treatment of anxiety.
Topics: Adult; Alprazolam; Anxiety Disorders; Depression; Double-Blind Method; Female; Humans; Male; Middle | 1987 |
Psychopharmacological treatment of panic disorder and related states: a placebo controlled study of alprazolam.
Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Dose-Response Relationship, Drug; Fear; Humans; Panic; P | 1987 |
Psychopharmacological treatment of panic disorder and related states: a placebo controlled study of alprazolam.
Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Dose-Response Relationship, Drug; Fear; Humans; Panic; P | 1987 |
Serotonin function in panic disorders. The effect of intravenous tryptophan in healthy subjects and patients with panic disorder before and during alprazolam treatment.
Topics: Adult; Alprazolam; Anxiety Disorders; Fear; Female; Humans; Male; Panic; Prolactin; Secretory Rate; | 1986 |
Serotonin function in panic disorders. The effect of intravenous tryptophan in healthy subjects and patients with panic disorder before and during alprazolam treatment.
Topics: Adult; Alprazolam; Anxiety Disorders; Fear; Female; Humans; Male; Panic; Prolactin; Secretory Rate; | 1986 |
Other Studies
120 other studies available for alprazolam and Anxiety Disorders
Article | Year |
---|---|
Effects of plasma concentration of micro-RNA Mir-27b and CYP3A4*22 on equilibrium concentration of alprazolam in patients with anxiety disorders comorbid with alcohol use disorder.
Topics: Adult; Alcoholism; Alprazolam; Anxiety Disorders; Biomarkers; Biotransformation; Comorbidity; Cytoch | 2020 |
Effects of plasma concentration of micro-RNA Mir-27b and CYP3A4*22 on equilibrium concentration of alprazolam in patients with anxiety disorders comorbid with alcohol use disorder.
Topics: Adult; Alcoholism; Alprazolam; Anxiety Disorders; Biomarkers; Biotransformation; Comorbidity; Cytoch | 2020 |
Dilated pupils in an anxious patient.
Topics: Alprazolam; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Anxiety Disorders; Citalo | 2021 |
Dilated pupils in an anxious patient.
Topics: Alprazolam; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Anxiety Disorders; Citalo | 2021 |
["Factitious disorder and skin picking: Clinical approach". A case report].
Topics: Alprazolam; Anxiety Disorders; Comorbidity; Diagnosis, Differential; Disruptive, Impulse Control, an | 2014 |
["Factitious disorder and skin picking: Clinical approach". A case report].
Topics: Alprazolam; Anxiety Disorders; Comorbidity; Diagnosis, Differential; Disruptive, Impulse Control, an | 2014 |
Severity of alprazolam dependence and associated features among long-term alprazolam users from psychiatric outpatient clinics in Taiwan.
Topics: Adult; Alprazolam; Ambulatory Care Facilities; Anti-Anxiety Agents; Anxiety Disorders; Comorbidity; | 2015 |
Severity of alprazolam dependence and associated features among long-term alprazolam users from psychiatric outpatient clinics in Taiwan.
Topics: Adult; Alprazolam; Ambulatory Care Facilities; Anti-Anxiety Agents; Anxiety Disorders; Comorbidity; | 2015 |
Animal behavior case of the month. Excessive fear of the unfamiliar in a dog.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Behavior, Animal | 2014 |
Animal behavior case of the month. Excessive fear of the unfamiliar in a dog.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Behavior, Animal | 2014 |
Animal behavior case of the month. Fear-related aggression.
Topics: Aggression; Alprazolam; Animals; Anti-Anxiety Agents; Anxiety Disorders; Behavior, Animal; Dogs; Fea | 2014 |
Animal behavior case of the month. Fear-related aggression.
Topics: Aggression; Alprazolam; Animals; Anti-Anxiety Agents; Anxiety Disorders; Behavior, Animal; Dogs; Fea | 2014 |
Paradoxical reactions related to alprazolam.
Topics: Adolescent; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Humans; Male; Self-Injurious Behavio | 2015 |
Paradoxical reactions related to alprazolam.
Topics: Adolescent; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Humans; Male; Self-Injurious Behavio | 2015 |
Comparative efficacy of pregabalin and benzodiazepines in treating the psychic and somatic symptoms of generalized anxiety disorder.
Topics: Adolescent; Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Dose-Response Relationship, D | 2010 |
Comparative efficacy of pregabalin and benzodiazepines in treating the psychic and somatic symptoms of generalized anxiety disorder.
Topics: Adolescent; Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Dose-Response Relationship, D | 2010 |
Treating anxiety without SSRIs.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anticonvulsants; Anxiety Disorders; Benzodiazepines; Comorbi | 2010 |
Treating anxiety without SSRIs.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anticonvulsants; Anxiety Disorders; Benzodiazepines; Comorbi | 2010 |
Overexpression of CB2 cannabinoid receptors decreased vulnerability to anxiety and impaired anxiolytic action of alprazolam in mice.
Topics: Alprazolam; Amygdala; Animals; Anti-Anxiety Agents; Anxiety; Anxiety Disorders; Gene Expression; Hip | 2011 |
Overexpression of CB2 cannabinoid receptors decreased vulnerability to anxiety and impaired anxiolytic action of alprazolam in mice.
Topics: Alprazolam; Amygdala; Animals; Anti-Anxiety Agents; Anxiety; Anxiety Disorders; Gene Expression; Hip | 2011 |
High doses alprazolam induced amenorrhoea and galactorrhoea.
Topics: Adult; Alprazolam; Amenorrhea; Anti-Anxiety Agents; Anxiety Disorders; Delayed-Action Preparations; | 2011 |
High doses alprazolam induced amenorrhoea and galactorrhoea.
Topics: Adult; Alprazolam; Amenorrhea; Anti-Anxiety Agents; Anxiety Disorders; Delayed-Action Preparations; | 2011 |
Don't ask, don't tell, but benzodiazepines are still the leading treatments for anxiety disorder.
Topics: Alprazolam; Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Drug Therapy, Combination | 2002 |
Don't ask, don't tell, but benzodiazepines are still the leading treatments for anxiety disorder.
Topics: Alprazolam; Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Drug Therapy, Combination | 2002 |
Effect of prenatal alprazolam exposure on anxiety patterns in rat offspring.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Anxiety Disorders; Behavior, Animal; Exploratory Behavior; | 2002 |
Effect of prenatal alprazolam exposure on anxiety patterns in rat offspring.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Anxiety Disorders; Behavior, Animal; Exploratory Behavior; | 2002 |
The role of extended-release benzodiazepines in the treatment of anxiety: a risk-benefit evaluation with a focus on extended-release alprazolam.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Clinical Trials as Topic; Delay | 2002 |
The role of extended-release benzodiazepines in the treatment of anxiety: a risk-benefit evaluation with a focus on extended-release alprazolam.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Clinical Trials as Topic; Delay | 2002 |
New drug and dosage form.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Drug Approval; Exenatide; Humans; Hypoglycemic A | 2005 |
New drug and dosage form.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Drug Approval; Exenatide; Humans; Hypoglycemic A | 2005 |
Topiramate use in alprazolam addiction.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anticonvulsants; Antidepressive Agents, Second-Generation; A | 2006 |
Topiramate use in alprazolam addiction.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anticonvulsants; Antidepressive Agents, Second-Generation; A | 2006 |
Clinical experience of the use of a pharmacological treatment algorithm for major depressive disorder in patients with advanced cancer.
Topics: Adult; Aged; Algorithms; Alprazolam; Amitriptyline; Antidepressive Agents; Anxiety Disorders; Benzod | 2008 |
Clinical experience of the use of a pharmacological treatment algorithm for major depressive disorder in patients with advanced cancer.
Topics: Adult; Aged; Algorithms; Alprazolam; Amitriptyline; Antidepressive Agents; Anxiety Disorders; Benzod | 2008 |
Sublingual use of olanzapine in combination with alprazolam to treat agitation in a terminally ill patient receiving parenteral nutrition.
Topics: Administration, Sublingual; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Hum | 2007 |
Sublingual use of olanzapine in combination with alprazolam to treat agitation in a terminally ill patient receiving parenteral nutrition.
Topics: Administration, Sublingual; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Hum | 2007 |
Pregabalin in benzodiazepine withdrawal.
Topics: Adult; Alprazolam; Anticonvulsants; Anxiety Disorders; gamma-Aminobutyric Acid; Humans; Hypnotics an | 2007 |
Pregabalin in benzodiazepine withdrawal.
Topics: Adult; Alprazolam; Anticonvulsants; Anxiety Disorders; gamma-Aminobutyric Acid; Humans; Hypnotics an | 2007 |
Pharmacology of neuropeptide S in mice: therapeutic relevance to anxiety disorders.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Anxiety Disorders; Arousal | 2008 |
Pharmacology of neuropeptide S in mice: therapeutic relevance to anxiety disorders.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Anxiety Disorders; Arousal | 2008 |
[Anxiety level and addiction to first-time prescriptions of anxiolytics: a psychometric study].
Topics: Adult; Aged; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Bromazepam; Cardio | 2008 |
[Anxiety level and addiction to first-time prescriptions of anxiolytics: a psychometric study].
Topics: Adult; Aged; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Bromazepam; Cardio | 2008 |
Alprazolam (Xanax, the Upjohn Company).
Topics: Adjustment Disorders; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Depressiv | 1981 |
Alprazolam (Xanax, the Upjohn Company).
Topics: Adjustment Disorders; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Depressiv | 1981 |
Alprazolam (Xanax).
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Depressive Disorder; Humans | 1982 |
Alprazolam (Xanax).
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Depressive Disorder; Humans | 1982 |
Panic disorder may respond to new 'antidepressants'.
Topics: Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Fear; Female; Huma | 1982 |
Panic disorder may respond to new 'antidepressants'.
Topics: Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Fear; Female; Huma | 1982 |
Alprazolam for panic disorder and depression.
Topics: Adolescent; Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Depressive D | 1983 |
Alprazolam for panic disorder and depression.
Topics: Adolescent; Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Depressive D | 1983 |
Endogenous anxiety: implications for nosology and treatment.
Topics: Adult; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Female; Gal | 1983 |
Endogenous anxiety: implications for nosology and treatment.
Topics: Adult; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Female; Gal | 1983 |
Delirium and seizures due to abrupt alprazolam withdrawal: case report.
Topics: Aged; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Delirium; Half-Life; Huma | 1984 |
Delirium and seizures due to abrupt alprazolam withdrawal: case report.
Topics: Aged; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Delirium; Half-Life; Huma | 1984 |
Alprazolam as treatment for a case of obsessive-compulsive disorder.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Humans; Male; Obsessive- | 1984 |
Alprazolam as treatment for a case of obsessive-compulsive disorder.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Humans; Male; Obsessive- | 1984 |
Emergence of hostility during alprazolam treatment.
Topics: Adult; Alprazolam; Anger; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Depressive Disord | 1984 |
Emergence of hostility during alprazolam treatment.
Topics: Adult; Alprazolam; Anger; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Depressive Disord | 1984 |
Treatment of panic attacks with alprazolam and propranolol.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Drug Synergism; Drug The | 1984 |
Treatment of panic attacks with alprazolam and propranolol.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Drug Synergism; Drug The | 1984 |
Alprazolam--a new triazolobenzodiazepine.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Depressive Disorder; Drug Inter | 1984 |
Alprazolam--a new triazolobenzodiazepine.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Depressive Disorder; Drug Inter | 1984 |
Successful treatment of endogenous depression with alprazolam in a patient with recent cardiac disease: case report.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Coronary Disease; Depressive Di | 1984 |
Successful treatment of endogenous depression with alprazolam in a patient with recent cardiac disease: case report.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Coronary Disease; Depressive Di | 1984 |
Delineation of anxiety and phobic disorders responsive to monoamine oxidase inhibitors: implications for classification.
Topics: Alprazolam; Anxiety Disorders; Benzodiazepines; Bupropion; Depressive Disorder; Dexamethasone; Fear; | 1984 |
Delineation of anxiety and phobic disorders responsive to monoamine oxidase inhibitors: implications for classification.
Topics: Alprazolam; Anxiety Disorders; Benzodiazepines; Bupropion; Depressive Disorder; Dexamethasone; Fear; | 1984 |
Panic attack syndrome.
Topics: Alprazolam; Antidepressive Agents; Anxiety Disorders; Benzodiazepines; Child; Fear; Humans; Hyperven | 1984 |
Panic attack syndrome.
Topics: Alprazolam; Antidepressive Agents; Anxiety Disorders; Benzodiazepines; Child; Fear; Humans; Hyperven | 1984 |
Psychopharmacologic treatment of panic disorder.
Topics: Alprazolam; Antidepressive Agents, Tricyclic; Anxiety Disorders; Benzodiazepines; Depressive Disorde | 1984 |
Psychopharmacologic treatment of panic disorder.
Topics: Alprazolam; Antidepressive Agents, Tricyclic; Anxiety Disorders; Benzodiazepines; Depressive Disorde | 1984 |
The use of alprazolam.
Topics: Adult; Alprazolam; Anxiety Disorders; Benzodiazepines; Fear; Humans; Male; Panic | 1984 |
The use of alprazolam.
Topics: Adult; Alprazolam; Anxiety Disorders; Benzodiazepines; Fear; Humans; Male; Panic | 1984 |
Serum dopamine-beta-hydroxylase activity in depression and anxiety.
Topics: Adult; Aged; Alprazolam; Anxiety; Anxiety Disorders; Benzodiazepines; Depression; Depressive Disorde | 1984 |
Serum dopamine-beta-hydroxylase activity in depression and anxiety.
Topics: Adult; Aged; Alprazolam; Anxiety; Anxiety Disorders; Benzodiazepines; Depression; Depressive Disorde | 1984 |
Clinical aspects of chronic use of alprazolam and lorazepam.
Topics: Alprazolam; Ambulatory Care; Anxiety Disorders; Depressive Disorder; Drug Administration Schedule; F | 1995 |
Clinical aspects of chronic use of alprazolam and lorazepam.
Topics: Alprazolam; Ambulatory Care; Anxiety Disorders; Depressive Disorder; Drug Administration Schedule; F | 1995 |
Upjohn responds to Consumer Reports letter.
Topics: Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Drug Industry; Drug Utilization; Humans; Pa | 1994 |
Upjohn responds to Consumer Reports letter.
Topics: Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Drug Industry; Drug Utilization; Humans; Pa | 1994 |
Response to "high anxiety".
Topics: Alprazolam; Anxiety Disorders; Dose-Response Relationship, Drug; Female; Humans; Panic Disorder; Ris | 1994 |
Response to "high anxiety".
Topics: Alprazolam; Anxiety Disorders; Dose-Response Relationship, Drug; Female; Humans; Panic Disorder; Ris | 1994 |
The effects of alprazolam on corticotropin-releasing factor neurons in the rat brain: implications for a role for CRF in the pathogenesis of anxiety disorders.
Topics: Alprazolam; Animals; Anxiety Disorders; Brain; Corticotropin-Releasing Hormone; Hypothalamo-Hypophys | 1993 |
The effects of alprazolam on corticotropin-releasing factor neurons in the rat brain: implications for a role for CRF in the pathogenesis of anxiety disorders.
Topics: Alprazolam; Animals; Anxiety Disorders; Brain; Corticotropin-Releasing Hormone; Hypothalamo-Hypophys | 1993 |
Anxiety sensitivity.
Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Benzodiazepines; Cognitive Behavioral Therapy; Combined | 1996 |
Anxiety sensitivity.
Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Benzodiazepines; Cognitive Behavioral Therapy; Combined | 1996 |
Clinical similarity and biological diversity in the response to alprazolam in patients with panic disorder and generalized anxiety disorder.
Topics: Adrenocorticotropic Hormone; Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Catecholamin | 1995 |
Clinical similarity and biological diversity in the response to alprazolam in patients with panic disorder and generalized anxiety disorder.
Topics: Adrenocorticotropic Hormone; Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Catecholamin | 1995 |
Alprazolam-induced hypomania.
Topics: Adult; Alprazolam; Anxiety Disorders; Bipolar Disorder; Depressive Disorder; Female; Humans; Psychia | 1996 |
Alprazolam-induced hypomania.
Topics: Adult; Alprazolam; Anxiety Disorders; Bipolar Disorder; Depressive Disorder; Female; Humans; Psychia | 1996 |
Graves'disease after the onset of panic disorder.
Topics: Alprazolam; Anxiety Disorders; Benzodiazepines; Female; Graves Disease; Humans; Hyperthyroidism; Lif | 1996 |
Graves'disease after the onset of panic disorder.
Topics: Alprazolam; Anxiety Disorders; Benzodiazepines; Female; Graves Disease; Humans; Hyperthyroidism; Lif | 1996 |
Method for assessing the duration of therapeutic action and milligram equivalence of anxiolytics.
Topics: Adolescent; Adult; Aged; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Delayed-Ac | 1996 |
Method for assessing the duration of therapeutic action and milligram equivalence of anxiolytics.
Topics: Adolescent; Adult; Aged; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Delayed-Ac | 1996 |
The realities of clonazepam discontinuation.
Topics: Alprazolam; Anxiety Disorders; Benzodiazepines; Clonazepam; Drug Administration Schedule; GABA Modul | 1997 |
The realities of clonazepam discontinuation.
Topics: Alprazolam; Anxiety Disorders; Benzodiazepines; Clonazepam; Drug Administration Schedule; GABA Modul | 1997 |
[Clinical effect of alprazolam and trazodone on bronchial asthmatics with anxiety disorder].
Topics: Adult; Aged; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Asthma; Female; Humans; Male; Middl | 1997 |
[Clinical effect of alprazolam and trazodone on bronchial asthmatics with anxiety disorder].
Topics: Adult; Aged; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Asthma; Female; Humans; Male; Middl | 1997 |
Gabapentin as a potential treatment for anxiety disorders.
Topics: Acetates; Adult; Alprazolam; Amines; Anticonvulsants; Anxiety Disorders; Cyclohexanecarboxylic Acids | 1998 |
Gabapentin as a potential treatment for anxiety disorders.
Topics: Acetates; Adult; Alprazolam; Amines; Anticonvulsants; Anxiety Disorders; Cyclohexanecarboxylic Acids | 1998 |
[Saliva level of free-3-methoxy-4-hydroxyphenylglycol in patients with anxiety disorders].
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Biomarkers; Female; Humans; Male; Methoxy | 1999 |
[Saliva level of free-3-methoxy-4-hydroxyphenylglycol in patients with anxiety disorders].
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Biomarkers; Female; Humans; Male; Methoxy | 1999 |
[Depression after age 50. Clinical case].
Topics: Aged; Alprazolam; Anxiety Disorders; Depressive Disorder; Drug Therapy, Combination; Female; Humans; | 2000 |
[Depression after age 50. Clinical case].
Topics: Aged; Alprazolam; Anxiety Disorders; Depressive Disorder; Drug Therapy, Combination; Female; Humans; | 2000 |
Role of dopaminergic and serotonergic systems on behavioral stimulatory effects of low-dose alprazolam and lorazepam.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Anxiety Disorders; Dopamine; Dose-Response Relationship, D | 2001 |
Role of dopaminergic and serotonergic systems on behavioral stimulatory effects of low-dose alprazolam and lorazepam.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Anxiety Disorders; Dopamine; Dose-Response Relationship, D | 2001 |
What are the issues surrounding long-term benzodiazepine treatment for generalized anxiety disorder.
Topics: Adult; Alprazolam; Anxiety Disorders; Benzodiazepines; Diazepam; Drug Administration Schedule; Femal | 1998 |
What are the issues surrounding long-term benzodiazepine treatment for generalized anxiety disorder.
Topics: Adult; Alprazolam; Anxiety Disorders; Benzodiazepines; Diazepam; Drug Administration Schedule; Femal | 1998 |
[A sudden relief from anxiety].
Topics: Alprazolam; Anti-Anxiety Agents; Antifungal Agents; Anxiety Disorders; Drug Interactions; Humans; It | 2000 |
[A sudden relief from anxiety].
Topics: Alprazolam; Anti-Anxiety Agents; Antifungal Agents; Anxiety Disorders; Drug Interactions; Humans; It | 2000 |
Seasonal panic disorder: a possible variant of seasonal affective disorder.
Topics: Adult; Alprazolam; Anxiety Disorders; Circadian Rhythm; Combined Modality Therapy; Depressive Disord | 1992 |
Seasonal panic disorder: a possible variant of seasonal affective disorder.
Topics: Adult; Alprazolam; Anxiety Disorders; Circadian Rhythm; Combined Modality Therapy; Depressive Disord | 1992 |
A prospective study of panic and anxiety in agoraphobia with panic disorder.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Arousal; Combined Modality Therapy; Desensitizati | 1992 |
A prospective study of panic and anxiety in agoraphobia with panic disorder.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Arousal; Combined Modality Therapy; Desensitizati | 1992 |
MDMA ("ecstasy") and panic disorder: induction by a single dose.
Topics: 3,4-Methylenedioxyamphetamine; Administration, Oral; Adult; Alprazolam; Anxiety Disorders; Arousal; | 1992 |
MDMA ("ecstasy") and panic disorder: induction by a single dose.
Topics: 3,4-Methylenedioxyamphetamine; Administration, Oral; Adult; Alprazolam; Anxiety Disorders; Arousal; | 1992 |
[Economic impact of integrating mental health in primary health care: apropos of a case].
Topics: Adult; Alprazolam; Antidepressive Agents; Anxiety Disorders; Humans; Interprofessional Relations; Ma | 1992 |
[Economic impact of integrating mental health in primary health care: apropos of a case].
Topics: Adult; Alprazolam; Antidepressive Agents; Anxiety Disorders; Humans; Interprofessional Relations; Ma | 1992 |
Panic disorder: strategies for long-term treatment.
Topics: Adolescent; Adult; Alprazolam; Anxiety Disorders; Diazepam; Female; Humans; Panic | 1991 |
Panic disorder: strategies for long-term treatment.
Topics: Adolescent; Adult; Alprazolam; Anxiety Disorders; Diazepam; Female; Humans; Panic | 1991 |
Prescription-event monitoring of 10,895 patients treated with alprazolam.
Topics: Adult; Aged; Alprazolam; Anxiety Disorders; Depressive Disorder; Drug Overdose; Female; Follow-Up St | 1991 |
Prescription-event monitoring of 10,895 patients treated with alprazolam.
Topics: Adult; Aged; Alprazolam; Anxiety Disorders; Depressive Disorder; Drug Overdose; Female; Follow-Up St | 1991 |
Exacerbation of panic disorder in a woman treated with trimethoprim-sulfamethoxazole.
Topics: Alprazolam; Anxiety Disorders; Drug Therapy, Combination; Female; Humans; Imipramine; Middle Aged; P | 1991 |
Exacerbation of panic disorder in a woman treated with trimethoprim-sulfamethoxazole.
Topics: Alprazolam; Anxiety Disorders; Drug Therapy, Combination; Female; Humans; Imipramine; Middle Aged; P | 1991 |
Switching from alprazolam to buspirone.
Topics: Alprazolam; Anxiety Disorders; Buspirone; Humans; Psychiatric Status Rating Scales; Substance Withdr | 1991 |
Switching from alprazolam to buspirone.
Topics: Alprazolam; Anxiety Disorders; Buspirone; Humans; Psychiatric Status Rating Scales; Substance Withdr | 1991 |
From the Food and Drug administration.
Topics: Alprazolam; Anxiety Disorders; Barium Sulfate; Communicable Disease Control; Dentists; Enema; Forms | 1990 |
From the Food and Drug administration.
Topics: Alprazolam; Anxiety Disorders; Barium Sulfate; Communicable Disease Control; Dentists; Enema; Forms | 1990 |
Longitudinal course of panic disorder: findings from the Massachusetts General Hospital Naturalistic Study.
Topics: Alprazolam; Anxiety Disorders; Child, Preschool; Chronic Disease; Clonazepam; Cognitive Behavioral T | 1990 |
Longitudinal course of panic disorder: findings from the Massachusetts General Hospital Naturalistic Study.
Topics: Alprazolam; Anxiety Disorders; Child, Preschool; Chronic Disease; Clonazepam; Cognitive Behavioral T | 1990 |
Treatment effects of alprazolam and imipramine: physiological versus subjective changes in patients with generalized anxiety disorder.
Topics: Adult; Alprazolam; Anxiety Disorders; Arousal; Electromyography; Epinephrine; Female; Heart Rate; Hu | 1990 |
Treatment effects of alprazolam and imipramine: physiological versus subjective changes in patients with generalized anxiety disorder.
Topics: Adult; Alprazolam; Anxiety Disorders; Arousal; Electromyography; Epinephrine; Female; Heart Rate; Hu | 1990 |
Switching patients from alprazolam to clonazepam.
Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Clonazepam; Dose-Response Relationship, Drug; Drug Admin | 1990 |
Switching patients from alprazolam to clonazepam.
Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Clonazepam; Dose-Response Relationship, Drug; Drug Admin | 1990 |
Reduction of gastrointestinal symptoms following treatment for panic disorder.
Topics: Adult; Alprazolam; Anxiety Disorders; Colonic Diseases, Functional; Diazepam; Fear; Female; Gastroin | 1990 |
Reduction of gastrointestinal symptoms following treatment for panic disorder.
Topics: Adult; Alprazolam; Anxiety Disorders; Colonic Diseases, Functional; Diazepam; Fear; Female; Gastroin | 1990 |
Plasma concentrations of melatonin in panic disorder.
Topics: Adult; Alprazolam; Anxiety Disorders; Circadian Rhythm; Fear; Female; Humans; Male; Melatonin; Panic | 1990 |
Plasma concentrations of melatonin in panic disorder.
Topics: Adult; Alprazolam; Anxiety Disorders; Circadian Rhythm; Fear; Female; Humans; Male; Melatonin; Panic | 1990 |
A patient with panic disorder eventuating in psychosis: nosology implications, Vol. 14, No. 3, September, 1989.
Topics: Alprazolam; Anxiety Disorders; Fear; Female; Humans; Panic; Psychoses, Substance-Induced; Substance | 1990 |
A patient with panic disorder eventuating in psychosis: nosology implications, Vol. 14, No. 3, September, 1989.
Topics: Alprazolam; Anxiety Disorders; Fear; Female; Humans; Panic; Psychoses, Substance-Induced; Substance | 1990 |
Severe withdrawal symptoms after discontinuation of alprazolam in eight patients with combat-induced posttraumatic stress disorder.
Topics: Adult; Alprazolam; Anxiety Disorders; Benzodiazepines; Combat Disorders; Depressive Disorder; Homici | 1990 |
Severe withdrawal symptoms after discontinuation of alprazolam in eight patients with combat-induced posttraumatic stress disorder.
Topics: Adult; Alprazolam; Anxiety Disorders; Benzodiazepines; Combat Disorders; Depressive Disorder; Homici | 1990 |
Mania in a panic disorder patient treated with fluoxetine.
Topics: Adult; Alprazolam; Anxiety Disorders; Bipolar Disorder; Fear; Fluoxetine; Humans; Male; Panic | 1990 |
Mania in a panic disorder patient treated with fluoxetine.
Topics: Adult; Alprazolam; Anxiety Disorders; Bipolar Disorder; Fear; Fluoxetine; Humans; Male; Panic | 1990 |
The relationship of panic disorder and its treatment outcome to 24-hour urinary MHPG levels.
Topics: Adolescent; Adult; Aged; Alprazolam; Anxiety Disorders; Diazepam; Double-Blind Method; Fear; Glycols | 1989 |
The relationship of panic disorder and its treatment outcome to 24-hour urinary MHPG levels.
Topics: Adolescent; Adult; Aged; Alprazolam; Anxiety Disorders; Diazepam; Double-Blind Method; Fear; Glycols | 1989 |
Buspirone and transvestic fetishism.
Topics: Alprazolam; Anxiety Disorders; Buspirone; Fetishism, Psychiatric; Humans; Male; Paraphilic Disorders | 1989 |
Buspirone and transvestic fetishism.
Topics: Alprazolam; Anxiety Disorders; Buspirone; Fetishism, Psychiatric; Humans; Male; Paraphilic Disorders | 1989 |
Imipramine and alprazolam treatment of lactate-induced acute endogenous distress in nonhuman primates.
Topics: Alprazolam; Animals; Anxiety Disorders; Behavior, Animal; Conditioning, Psychological; Fear; Homing | 1989 |
Imipramine and alprazolam treatment of lactate-induced acute endogenous distress in nonhuman primates.
Topics: Alprazolam; Animals; Anxiety Disorders; Behavior, Animal; Conditioning, Psychological; Fear; Homing | 1989 |
Symptoms and treatment responses of generalized anxiety disorder patients with high versus low levels of cardiovascular complaints.
Topics: Adult; Alprazolam; Anxiety Disorders; Female; Heart Diseases; Heart Rate; Humans; Imipramine; Male; | 1989 |
Symptoms and treatment responses of generalized anxiety disorder patients with high versus low levels of cardiovascular complaints.
Topics: Adult; Alprazolam; Anxiety Disorders; Female; Heart Diseases; Heart Rate; Humans; Imipramine; Male; | 1989 |
Panic disorder: diagnosis and treatment.
Topics: Alprazolam; Antidepressive Agents, Tricyclic; Anxiety Disorders; Fear; Humans; Monoamine Oxidase Inh | 1989 |
Panic disorder: diagnosis and treatment.
Topics: Alprazolam; Antidepressive Agents, Tricyclic; Anxiety Disorders; Fear; Humans; Monoamine Oxidase Inh | 1989 |
Pharmacological dissection of panic and depersonalization.
Topics: Adolescent; Alprazolam; Anxiety Disorders; Depersonalization; Fear; Female; Fluoxetine; Humans; Imip | 1989 |
Pharmacological dissection of panic and depersonalization.
Topics: Adolescent; Alprazolam; Anxiety Disorders; Depersonalization; Fear; Female; Fluoxetine; Humans; Imip | 1989 |
Depression in panic disorder and response to alprazolam therapy.
Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Depressive Disorder; Fear; Humans; Panic; Psychiatric St | 1989 |
Depression in panic disorder and response to alprazolam therapy.
Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Depressive Disorder; Fear; Humans; Panic; Psychiatric St | 1989 |
Clinical and medication outcome after short-term alprazolam and behavioral group treatment in panic disorder. 2.5 year naturalistic follow-up study.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Behavior Therapy; Combined Modality Therapy; Depr | 1989 |
Clinical and medication outcome after short-term alprazolam and behavioral group treatment in panic disorder. 2.5 year naturalistic follow-up study.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Behavior Therapy; Combined Modality Therapy; Depr | 1989 |
Action of imipramine and alprazolam in panic disorder.
Topics: Alprazolam; Anxiety Disorders; Fear; Humans; Imipramine; Panic; Receptors, Adrenergic; Receptors, GA | 1988 |
Action of imipramine and alprazolam in panic disorder.
Topics: Alprazolam; Anxiety Disorders; Fear; Humans; Imipramine; Panic; Receptors, Adrenergic; Receptors, GA | 1988 |
A withdrawal syndrome after abrupt discontinuation of alprazolam.
Topics: Adult; Agoraphobia; Akathisia, Drug-Induced; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Ben | 1985 |
A withdrawal syndrome after abrupt discontinuation of alprazolam.
Topics: Adult; Agoraphobia; Akathisia, Drug-Induced; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Ben | 1985 |
Noradrenergic function and the mechanism of action of antianxiety treatment. I. The effect of long-term alprazolam treatment.
Topics: Adult; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Blood Press | 1985 |
Noradrenergic function and the mechanism of action of antianxiety treatment. I. The effect of long-term alprazolam treatment.
Topics: Adult; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Blood Press | 1985 |
Three case reports of acute paroxysmal excitement associated with alprazolam treatment.
Topics: Acute Disease; Adult; Akathisia, Drug-Induced; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; B | 1985 |
Three case reports of acute paroxysmal excitement associated with alprazolam treatment.
Topics: Acute Disease; Adult; Akathisia, Drug-Induced; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; B | 1985 |
Seizures following the withdrawal of alprazolam.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Female; Humans; Panic; S | 1986 |
Seizures following the withdrawal of alprazolam.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Female; Humans; Panic; S | 1986 |
Preliminary evidence for the utility of carbamazepine in alprazolam withdrawal.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Carbamazepine; Female; H | 1986 |
Preliminary evidence for the utility of carbamazepine in alprazolam withdrawal.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Carbamazepine; Female; H | 1986 |
Alprazolam-induced ejaculatory inhibition.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Ejaculation; Humans; Male; Midd | 1986 |
Alprazolam-induced ejaculatory inhibition.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Ejaculation; Humans; Male; Midd | 1986 |
A case of alprazolam-related hepatitis.
Topics: Adult; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Chemical an | 1986 |
A case of alprazolam-related hepatitis.
Topics: Adult; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Chemical an | 1986 |
Alprazolam-induced manic episode in two patients with panic disorder.
Topics: Adult; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Bipolar Dis | 1986 |
Alprazolam-induced manic episode in two patients with panic disorder.
Topics: Adult; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Bipolar Dis | 1986 |
Postpanic anxiety disorder: diagnosis and treatment.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Athletic Injuries; Benzodiazepines; Desen | 1986 |
Postpanic anxiety disorder: diagnosis and treatment.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Athletic Injuries; Benzodiazepines; Desen | 1986 |
Alprazolam treatment for panic disorders.
Topics: Adult; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Fear; Femal | 1986 |
Alprazolam treatment for panic disorders.
Topics: Adult; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Fear; Femal | 1986 |
How antipanic drugs might work.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Fear; Female; Humans; Im | 1986 |
How antipanic drugs might work.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Fear; Female; Humans; Im | 1986 |
Biological markers in panic states: lactate-induced panic and mitral valve prolapse.
Topics: Adolescent; Adult; Aged; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Creatinine | 1987 |
Biological markers in panic states: lactate-induced panic and mitral valve prolapse.
Topics: Adolescent; Adult; Aged; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Creatinine | 1987 |
Adjunctive alprazolam for schizophrenia with panic anxiety: clinical observation and pathogenetic implications.
Topics: Adolescent; Adult; Alprazolam; Antipsychotic Agents; Anxiety Disorders; Dopamine; Drug Therapy, Comb | 1988 |
Adjunctive alprazolam for schizophrenia with panic anxiety: clinical observation and pathogenetic implications.
Topics: Adolescent; Adult; Alprazolam; Antipsychotic Agents; Anxiety Disorders; Dopamine; Drug Therapy, Comb | 1988 |
Alprazolam treatment of avoidant personality traits in social phobic patients.
Topics: Adult; Alprazolam; Anxiety Disorders; Female; Humans; Male; Panic; Personality Disorders; Phobic Dis | 1989 |
Alprazolam treatment of avoidant personality traits in social phobic patients.
Topics: Adult; Alprazolam; Anxiety Disorders; Female; Humans; Male; Panic; Personality Disorders; Phobic Dis | 1989 |
Clonazepam blockade of spontaneous and CO2 inhalation-provoked panic in a patient with panic disorder.
Topics: Adult; Alprazolam; Anxiety Disorders; Benzodiazepines; Benzodiazepinones; Carbon Dioxide; Clonazepam | 1986 |
Clonazepam blockade of spontaneous and CO2 inhalation-provoked panic in a patient with panic disorder.
Topics: Adult; Alprazolam; Anxiety Disorders; Benzodiazepines; Benzodiazepinones; Carbon Dioxide; Clonazepam | 1986 |
Alprazolam dependence in seven patients.
Topics: Adult; Alcoholism; Alprazolam; Anxiety Disorders; Depressive Disorder; Female; Humans; Male; Marijua | 1988 |
Alprazolam dependence in seven patients.
Topics: Adult; Alcoholism; Alprazolam; Anxiety Disorders; Depressive Disorder; Female; Humans; Male; Marijua | 1988 |
Alprazolam in the treatment of social phobia.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Female; Humans; Male; Middle Aged; Panic; Phobic | 1988 |
Alprazolam in the treatment of social phobia.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Female; Humans; Male; Middle Aged; Panic; Phobic | 1988 |
Alprazolam in the treatment of panic attack patients with and without major depression.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Depressive Disorder; Fear; Female; Humans; Male; | 1988 |
Alprazolam in the treatment of panic attack patients with and without major depression.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Depressive Disorder; Fear; Female; Humans; Male; | 1988 |
Alprazolam plus buspirone in treatment of anxiety.
Topics: Adult; Alprazolam; Ambulatory Care; Anxiety Disorders; Buspirone; Drug Therapy, Combination; Female; | 1988 |
Alprazolam plus buspirone in treatment of anxiety.
Topics: Adult; Alprazolam; Ambulatory Care; Anxiety Disorders; Buspirone; Drug Therapy, Combination; Female; | 1988 |
Alprazolam dependency: use of clonazepam for withdrawal.
Topics: Adult; Alprazolam; Anxiety Disorders; Clonazepam; Humans; Hydrocortisone; Male; Substance Withdrawal | 1988 |
Alprazolam dependency: use of clonazepam for withdrawal.
Topics: Adult; Alprazolam; Anxiety Disorders; Clonazepam; Humans; Hydrocortisone; Male; Substance Withdrawal | 1988 |
Patients with panic attacks and abnormal EEG results.
Topics: Adult; Alprazolam; Anxiety Disorders; Brain; Carbamazepine; Electroencephalography; Fear; Female; Hu | 1987 |
Patients with panic attacks and abnormal EEG results.
Topics: Adult; Alprazolam; Anxiety Disorders; Brain; Carbamazepine; Electroencephalography; Fear; Female; Hu | 1987 |
Schizophrenia, panic anxiety, and alprazolam.
Topics: Adult; Alprazolam; Anxiety Disorders; Drug Therapy, Combination; Fear; Haloperidol; Humans; Male; Pa | 1987 |
Schizophrenia, panic anxiety, and alprazolam.
Topics: Adult; Alprazolam; Anxiety Disorders; Drug Therapy, Combination; Fear; Haloperidol; Humans; Male; Pa | 1987 |
Emergence of depressive symptoms in patients receiving alprazolam for panic disorder.
Topics: Adult; Alprazolam; Anxiety Disorders; Depressive Disorder; Drug Therapy, Combination; Fear; Female; | 1987 |
Emergence of depressive symptoms in patients receiving alprazolam for panic disorder.
Topics: Adult; Alprazolam; Anxiety Disorders; Depressive Disorder; Drug Therapy, Combination; Fear; Female; | 1987 |
Combined alprazolam and phenelzine treatment of refractory depression with panic attacks.
Topics: Adult; Alprazolam; Anxiety Disorders; Depressive Disorder; Drug Therapy, Combination; Fear; Humans; | 1987 |
Combined alprazolam and phenelzine treatment of refractory depression with panic attacks.
Topics: Adult; Alprazolam; Anxiety Disorders; Depressive Disorder; Drug Therapy, Combination; Fear; Humans; | 1987 |
Alprazolam treatment for panic disorder.
Topics: Adult; Alprazolam; Anxiety Disorders; Fear; Female; Humans; Male; Panic; Substance Withdrawal Syndro | 1987 |
Alprazolam treatment for panic disorder.
Topics: Adult; Alprazolam; Anxiety Disorders; Fear; Female; Humans; Male; Panic; Substance Withdrawal Syndro | 1987 |
The alprazolam to clonazepam switch for the treatment of panic disorder.
Topics: Alprazolam; Anxiety Disorders; Clonazepam; Fear; Humans; Panic | 1987 |
The alprazolam to clonazepam switch for the treatment of panic disorder.
Topics: Alprazolam; Anxiety Disorders; Clonazepam; Fear; Humans; Panic | 1987 |
"Panic disorder" in schizophrenia.
Topics: Adult; Alprazolam; Anxiety Disorders; Fear; Fluphenazine; Humans; Male; Panic; Schizophrenic Psychol | 1987 |
"Panic disorder" in schizophrenia.
Topics: Adult; Alprazolam; Anxiety Disorders; Fear; Fluphenazine; Humans; Male; Panic; Schizophrenic Psychol | 1987 |
Synergistic action of alprazolam with tranylcypromine in drug-resistant atypical depression with panic attacks.
Topics: Alprazolam; Antidepressive Agents; Anxiety Disorders; Benzodiazepines; Depressive Disorder; Drug Res | 1986 |
Synergistic action of alprazolam with tranylcypromine in drug-resistant atypical depression with panic attacks.
Topics: Alprazolam; Antidepressive Agents; Anxiety Disorders; Benzodiazepines; Depressive Disorder; Drug Res | 1986 |
Treatment of panic disorder and agoraphobia with clonazepam.
Topics: Adolescent; Adult; Aged; Agoraphobia; Alprazolam; Anxiety Disorders; Benzodiazepines; Benzodiazepino | 1986 |
Treatment of panic disorder and agoraphobia with clonazepam.
Topics: Adolescent; Adult; Aged; Agoraphobia; Alprazolam; Anxiety Disorders; Benzodiazepines; Benzodiazepino | 1986 |
The effect of state anxiety on personality measurement.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety; Anxiety Disorders; Benzodiazepines; Female; Humans; Male; P | 1986 |
The effect of state anxiety on personality measurement.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety; Anxiety Disorders; Benzodiazepines; Female; Humans; Male; P | 1986 |
Successful use of clonazepam in patients with treatment-resistant panic disorder.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Benzodiazepines; Benzodiazepinones; Clonazepam; D | 1986 |
Successful use of clonazepam in patients with treatment-resistant panic disorder.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Benzodiazepines; Benzodiazepinones; Clonazepam; D | 1986 |
Can panic disorder present as irritable bowel syndrome?
Topics: Adult; Alprazolam; Anxiety Disorders; Benzodiazepines; Colonic Diseases, Functional; Fear; Female; H | 1986 |
Can panic disorder present as irritable bowel syndrome?
Topics: Adult; Alprazolam; Anxiety Disorders; Benzodiazepines; Colonic Diseases, Functional; Fear; Female; H | 1986 |
Agitated depression, alprazolam, and panic anxiety.
Topics: Adult; Aged; Alprazolam; Antidepressive Agents; Anxiety Disorders; Benzodiazepines; Depressive Disor | 1986 |
Agitated depression, alprazolam, and panic anxiety.
Topics: Adult; Aged; Alprazolam; Antidepressive Agents; Anxiety Disorders; Benzodiazepines; Depressive Disor | 1986 |
Sequential treatment of panic disorder with alprazolam and imipramine.
Topics: Alprazolam; Anxiety Disorders; Drug Administration Schedule; Drug Therapy, Combination; Fear; Humans | 1986 |
Sequential treatment of panic disorder with alprazolam and imipramine.
Topics: Alprazolam; Anxiety Disorders; Drug Administration Schedule; Drug Therapy, Combination; Fear; Humans | 1986 |
Carbamazepine, alprazolam withdrawal, and panic disorder.
Topics: Alprazolam; Anxiety Disorders; Carbamazepine; Fear; Humans; Panic; Substance Withdrawal Syndrome | 1987 |
Carbamazepine, alprazolam withdrawal, and panic disorder.
Topics: Alprazolam; Anxiety Disorders; Carbamazepine; Fear; Humans; Panic; Substance Withdrawal Syndrome | 1987 |
A case of alprazolam, but not lorazepam, inducing manic symptoms.
Topics: Adult; Alprazolam; Anxiety Disorders; Bipolar Disorder; Female; Humans; Lorazepam; Panic | 1987 |
A case of alprazolam, but not lorazepam, inducing manic symptoms.
Topics: Adult; Alprazolam; Anxiety Disorders; Bipolar Disorder; Female; Humans; Lorazepam; Panic | 1987 |
Discontinuation of alprazolam treatment in panic patients.
Topics: Acute Disease; Adult; Alprazolam; Anxiety Disorders; Dizziness; Fear; Female; Humans; Male; Middle A | 1987 |
Discontinuation of alprazolam treatment in panic patients.
Topics: Acute Disease; Adult; Alprazolam; Anxiety Disorders; Dizziness; Fear; Female; Humans; Male; Middle A | 1987 |
Globus hystericus and panic attacks.
Topics: Adult; Alprazolam; Anxiety Disorders; Conversion Disorder; Fear; Female; Humans; Panic | 1987 |
Globus hystericus and panic attacks.
Topics: Adult; Alprazolam; Anxiety Disorders; Conversion Disorder; Fear; Female; Humans; Panic | 1987 |
A proposed clinical approach to chronic and "resistant" depressions: evaluation and treatment.
Topics: Alprazolam; Antidepressive Agents; Antidepressive Agents, Tricyclic; Anxiety Disorders; Benzodiazepi | 1985 |
A proposed clinical approach to chronic and "resistant" depressions: evaluation and treatment.
Topics: Alprazolam; Antidepressive Agents; Antidepressive Agents, Tricyclic; Anxiety Disorders; Benzodiazepi | 1985 |
Thyroid indices in panic disorder.
Topics: Adult; Alprazolam; Anxiety Disorders; Benzodiazepines; Fear; Female; Humans; Imipramine; Male; Middl | 1985 |
Thyroid indices in panic disorder.
Topics: Adult; Alprazolam; Anxiety Disorders; Benzodiazepines; Fear; Female; Humans; Imipramine; Male; Middl | 1985 |